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Mammalian oocyte research has benefited from gene manipulation tools such as 
homologous recombination, antisense and RNA interference, with limitations. Triplex-
forming oligonucleotides (TFOs) can modulate gene expression in a sequence specific 
manner. Their ability to directly target the gene makes them attractive as genome 
manipulation tools. The goal of this thesis project was to investigate the possibility of 
using TFOs to inhibit expression of genes that are important for the maturation or 
fertilization of oocytes in a mouse cell culture model system. 
Materials and methods   
We used a web-based search engine to identify TFO binding sites in Cd9, Plk1 
and Cdcd25b genes and selected some sequences for studies. We used biochemical, and 
cell biology approaches such as UV thermal denaturation, electrophoretic mobility shift 
assays, live cell fluorescence microscopy, RT-qPCR and western blot techniques to 
investigate the in vitro characteristics and in vivo activity of the TFOs.  
Results  
Only a small subset of the Cd9, Plk1 and Cdc25b deoxyribo-TFOs tested formed stable 
triplexes with their target DNA duplexes. 2’-OMe TFOs formed more stable triplexes and 
2’-OMe-Pt-TFOs cross-linked with higher efficiencies than their deoxyribo counterparts. 
FITC-labeled Cd9 T2 3’ Pt-TFO complexed to transfection reagents FuGENE HD or 
Lipofectamine
TM 
2000 had different uptake efficiencies and sub-cellular distribution. RT-




2000/FITC-labeled Cd9 T2 3’ Pt-TFO complex showed a 32% decrease in the Cd9 
mRNA level. However a similar decrease was observed when the cells were transfected 
with a Lipofectamine
TM
 2000/FITC-labeled scrambled 3’ Pt-TFO. No change in CD9 
protein levels was observed for either FITC-labeled scrambled or Cd9 3' Pt-TFO 
complexed to Lipofectamine
TM
 2000 or FuGENE HD. 
Conclusion 
2'-O-methylribo modification increases the stability of the triplexes formed by 
TFOs and the efficiency of cross-linking by Pt-TFOs. Our results indicate that uptake 
efficiency and nuclear localization differs for different transfection reagents and 
determines the in vivo activity of the Pt-TFO. Although the FITC-labeled Cd9 T2 3' Pt-
TFO demonstrated modest ability to inhibit the Cd9 mRNA levels we were unable to 
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 LITERATURE REVIEW   
1. Introduction  
Gene modulation technologies in biomedical research have facilitated the 
discovery of the functions of specific gene products, including their molecular 
mechanisms in a myriad of biological processes. These insights have far-reaching 
implications in basic science, and in clinical and therapeutic research.  In research of 
mammalian oocytes, genetic manipulations have provided significant insights into 
genes involved in processes such as cell cycle division, proliferation differentiation, 
and fertilization (Kaji et al., 2000; Lindqvist, Källström, & Karlsson Rosenthal, 2004). 
These studies and their outputs are of considerable interest due to their applications for 
human reproductive health.  
Traditionally, homologous recombination techniques have been used to 
generate knockout mice for studies to deduce gene function (Miyado et al., 2000; 
Torgasheva, Rubtsov, & Borodin, 2013). While efficient, this method is time and 
labor-intensive. Arguably, the Knockout Mouse Project provides significant access to 
a wide collection of mouse knockouts and embryonic stem cells (Austin et al., 2004) 
or mouse knockouts can be obtained from commercial resources. However, 
preparation of knockout mice can result in unpredicted phenotypes, which coupled 
with the high cost of production necessitates the need for additional efforts to achieve 
desired phenotypes (Austin et al., 2004).  Recently, different approaches including 
antisense oligonucleotides and RNA interference (RNAi) have emerged as genetic 
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manipulation tools useful for studying gene function in mammalian oocytes (Dias & 
Stein, 2002; Sarnova, Malik, Sedlacek, & Svoboda, 2010). 
Antisense oligonucleotides are single-stranded oligonucleotides targeting 
specific mRNA for degradation through an RNase mechanism or by sterically 
blocking the translation of the mRNA into the corresponding protein (Dias & Stein, 
2002). They have been used in mouse models to study the specific function of genes 
and their corresponding protein products (Kola & Sumarsono, 1995; Pal, Zinkel, 
Kiessling, & Cooper, 1991; Richards, Carroll, Kinloch, Wassarman, & Strickland, 
1993; Z. Tong, Nelson, & Dean, 1995). However, the application of antisense 
oligonucleotides is effectively limited by several difficulties, such as the potential 
displacement of the antisense oligonucleotides by ribosomal translational machinery, 
target inaccessibility (Dias & Stein, 2002), and limited efficacy due to the ability of 
the cell to replace lost mRNA (Mahato, Cheng, & Guntaka, 2005).  
Alternatively, RNAi is an advanced sequence-specific post-transcriptional 
regulator of mRNA.  These small RNA oligonucleotides are targeted to mRNA 
transcripts to induce either translation suppression or, more commonly, degradation of 
the mRNA (Mahato et al., 2005) The RNAi mechanism is a multistep process initiated 
when a precursor double-stranded RNA is processed by the RNase enzyme Dicer to 
generate small interfering RNA (siRNA) or micro-RNA (miRNAs), which become 
incorporated into the RNA-induced silencing complex (RISC).  
The complex recognizes target mRNAs homologous to the siRNA or miRNA and 
translationally blocks or degrades them (Barton & Medzhitov, 2002; Mahato et al., 
2005).  In contrast to standard recombination assays, RNAi-based genetic 
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manipulation is a cheaper, relatively simple tool with the potential to efficiently 
produce desired phenotypes (Sarnova et al., 2010). RNAi strategies have been used in 
several studies and have provided significant progress  in elucidating the molecular 
basis of key processes in oocytes (Arnold, Françon, Zhang, Martin, & Clarke, 2008; 
Fedoriw, Stein, Svoboda, Schultz, & Bartolomei, 2004; Han, Chen, Paronetto, & 
Conti, 2005; Igarashi, Knott, Schultz, & Williams, 2007). However, there are several 
potential problems with RNAi strategies, such as the labor-intensive process of 
obtaining effective RNAi molecules, effective delivery of RNAi molecules and non-
robust phenotypic expression due to insufficient protein knockdown. Additionally, in 
cases in which transgenic RNAi is attempted, one potential problem is epigenetic 
silencing of the transgene, resulting in  inconsistent expression of the transgene (Malik 
& Svoboda, 2012). These challenges suggest that alternatives to RNAi would be 
useful to study the functions of various genes in oocytes. Hence there is the need to 
develop fast, specific and cheap genetic manipulation strategies with the potential to 
generate more robust phenotypes.  
Triplex forming oligonucleotides (TFOs) are sequence-specific single-stranded 
DNA molecules that interact specifically with homopurine sequences in the DNA 
duplex to form triple-stranded complexes called triplexes (Felsenfeld & Rich, 1957). 
Because of their sequence specificity and high binding affinity, TFOs can modulate 
transcription of the gene by blocking RNA polymerase (Kim et al., 1998; Postel, Flint, 
Kessler, & Hogan, 1991). This approach presents an opportunity to manipulate 
specific genes of interest prior to the occurrence of transcription. The limited number 
of each gene target (two alleles or copies of each) in contrast to the large number of 
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RNA targets potentially provides some advantage to use of TFOs over the antisense 
and RNAi approaches. Both RNAi and antisense strategies can block the translation of 
mRNA and target the mRNA for degradation but do not prevent further transcription 
of the corresponding gene to restore the mRNA pool. TFO-mediated inhibition of gene 
transcription can in theory significantly reduce the mRNA concentration, an effective 
approach with potentially long-term effects (Mahato et al., 2005). Hence the ability of 
TFOs to modulate gene expression could be used to drive new genome manipulation 
approaches in mammalian oocyte biology research.  
 
2. Triplex-forming Oligonucleotides (TFOs)  
 
2.1 Chemistry of TFOs  
Initially discovered in 1957, triplex-forming oligonucleotides (TFOs) are 
single-stranded oligonucleotides that form a sequence specific triple helix by 
interacting with homopurine tracts in the major groove of the DNA duplex (Felsenfeld 
& Rich, 1957; Fox, 2000; Frank-Kamenetskii & Mirkin, 1995; Knauert & Glazer, 
2001a; Radhakrishnan & Patel, 1994). Two sequence-specific binding motifs of 
triplex helix formation have been identified: the polypyrimidine and the polypurine 
motifs (Figure 1).  As shown in Figure 1B, in the polypyrimidine motif TFOs, T 
recognizes A-T base pairs and protonated C recognizes G-C base pairs to form T.A-T 
and C.G-C base triads respectively by interacting through Hoogsteen hydrogen 
bonding in a parallel orientation to the purine strand of the duplex. In the polypurine 
motif, G recognizes G-C base pairs and A recognizes A-T bases pairs, interacting 
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through reverse Hoogsteen base pairing in an antiparallel orientation to the purine 
strand of the DNA duplex to form G.G-C and A.A-T base triads respectively (Figure 
1C) (Chan & Glazer, 1997; Cooney, Czernuszewicz, Postel, Flint, & Hogan, 1988; 
Maher, Wold, & Dervan, 1989; Young, Krawczyk, Matteucci, & Toole, 1991).  The 
stabilities of polypyrimidine triplexes are dependent upon pH because the N3 of the 
cytosines of the TFO must be protonated to provide the second Hoogsteen hydrogen 
bond to the N7 of the guanine in the target DNA duplex. The stability of purine motif 
triplexes are not pH dependent, though they can form G-rich intermolecular structures 
(Chan & Glazer, 1997; Escudeé et al., 1993; Radhakrishnan & Patel, 1994). 
 
2.2 TFO modifications that Enhance Triplex Stability  
The interactions between deoxyribose polypyrimidine TFOs and their target 
DNA duplex are generally weak, forming triplexes of low thermal stability. However, 
for biological applications, triplexes are required to have strong binding affinity under 
physiological conditions to effectively modulate the expression of the targeted gene. 
Evidence suggests that modifications to the nucleotides of polypyrimidine TFOs can  
significantly improve the stability of triplexes (Campbell & Miller, 2009a; Campbell 
& Miller, 2009b; Graham & Miller, 2012). These include modifications of the 
cytosine bases, the sugars and/or phosphate groups of the sugar-phosphate backbone, 
and conjugation of the TFOs with an alkylating agent.  
The requirement for protonation of the cytosines in deoxyribose 
polypyrimidine TFOs limits their application in cells because the intracellular pH is 
approximately 7.5. To circumvent this problem, deoxycytidines in polypyrimidine 
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TFOs can be replaced with 5-methylcytosines (Povsic & Dervan, 1989; Singleton & 
Dervan, 1992; Xodo, Manzini, Quadrifoglio, van der Marel, & van Boom, 1991) or 
N
6
-methyl-8-oxo-2-deoxyadenosine (Krawczyk et al., 1992) to decrease the pH 
dependence and enhance the triplex formation and stability at higher pH. 
It is possible to confer additional stability to the triplexes formed by 
polypyrimidine TFOs by replacing the deoxyribose sugar with 2'-O-methylribose (2'-
OMe) (Faria et al., 2000). This modification increases the Tm of the triplex compared 
to that of triplexes formed by polypyrimidine TFOs containing deoxyribose (Crooke, 
1992; Graham & Miller, 2012) and increases the resistance of the TFO to nuclease 
degradation (Inoue et al., 1987).  
The phosphodiester backbone can be modified to increase the triplex affinity 
and stability. These chemical modifications include phosphoramidates (Escudé, Sun, 
Rougée, Garestier, & Hélène, 1992), morpholino phosphoramidate linkages (Basye, 
Trent, Gao, & Ebbinghaus, 2001) and phosphorothioate linkages (Lacoste, François, & 
Hélène, 1997). The ability of the TFO to modulate the expression of the targeted gene 
depends on the duration of their interaction with the DNA duplex. The longer they 
interact with the target DNA duplex, the longer the antigene effect. Generally, 
unmodified TFOs have limited interactions with the target. The limited interaction of 
unmodified TFOs with their targets was first established by Young et al (1991), whose 
research demonstrated that unmodified TFOs can temporarily stall RNA polymerase 
and arrest transcription. However, RNA polymerase eventually displaces the TFO 
from the targeted DNA, resumes elongation and produces full-length transcript. 
However TFOs conjugated to a functional group that can covalently cross-link the 
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TFO to the target DNA, can effectively block transcription (Young et al., 1991). 
Consequently a variety of groups such as photoactivable psoralen (Besch et al., 2004; 
Giovannangéli, Thuong, & Héléne, 1992; Guieysse, Praseuth, Giovannangeli, 
Asseline, & Hélène, 2000; Havre, Gunther, Gasparro, & Glazer, 1993; Takasugi et al., 
1991), platinum derivatives (Colombier, Lippert, & Leng, 1996) and bromoacetamide 
(Taylor & Dervan, 1997) have been studied for their ability to cross-link TFOs to their 
target DNA duplexes.  
Platinum-derivatized TFOs (Pt-TFOs) have been studied for their ability to 
cross-link the TFO to the target duplex. Terminal guanine residues in the TFO can be 
reacted with transplatin to form a platinum derivatized TFO that, upon formation of 
the triplex, can react with the N7 of adjacent guanines in the target DNA duplex 
(Colombier, Lippert, & Leng, 1996). As shown in Figure 2A, the platinum residue is 
positioned at the N7 of the 3' terminal guanine of the TFO. Figure 2B shows the 
general structure of the platinated guanine and the coordination adduct formed by 
reaction of the platinum with a guanine. This allows the platinated guanine to reach 
across the major groove of the DNA duplex to form a cross-link with the adjacent G 
residue in the DNA duplex. This cross-link irreversibly links the TFO to the target 
duplex. When combined with nucleotide modifications, cross-link formation 






2.3 Biological Activities of TFOs  
Several in vitro and in vivo studies have provided insights into the potential 
applications of TFOs. These include gene transcription inhibition and modifications to 
the gene structure through recombination and mutations (Faruqi, Seidman, Segal, 
Carroll, & Glazer, 1996; Faruqi, Datta, Carroll, Seidman, & Glazer, 2000).  
Several reports have demonstrated the ability of TFOs to regulate gene 
expression through transcriptional inhibition. To inhibit transcription, TFOs can be 
targeted to the coding regions of genes (Cooney et al., 1988; Radhakrishnan & Patel, 
1994), or to the promoter regions (Duval-Valentin, Thuong, & Helene, 1992; Maher et 
al., 1989; Young et al., 1991). TFOs targeted to the promoter regions have been shown 
to inhibit transcription in vitro, as well as in vivo, through studies with cultured cells 
(Kim et al., 1998; Postel, Flint, Kessler, & Hogan, 1991). For example, a TFO targeted 
to a region of the human c-myc promoter blocked the transcription of the promoter 
region in vitro (Cooney et al., 1988), inhibiting the expression of the c-MYC gene. 
Duval-Valentine et al (1992) also demonstrated that a 13-mer TFO targeted to the E. 
coli B-lactamase gene downstream of the bla promoter prevents transcription 
initiation by E. coli RNA polymerase (Duval-Valentin, Thuong, & Helene, 1992).  In 
another experiment, using a phosphorothioate-modified polypurine TFO, and a 
luciferase reporter plasmid assay, Kim et al (1998) showed that a TFO targeted to the 
c-myc pro-oncogene in HeLa cells inhibited the transcription of the c-myc promoter as 
indicated by the decreased luciferase expression (Kim et al., 1998). 
TFOs have the potential to induce structural modifications of a targeted gene 
through recombination and mutation. TFOs targeted to specific regions of genes in 
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mammalian cells can induce recombination presumably through recognition of the 
triplex as damage by the repair machinery of the cell. Faruqi et al (1996) observed that 
a psoralen-conjugated polypurine TFO targeted to a region between two supF mutants 
in a dual supF tRNA reporter simian virus vector induced homologous recombination 
in the vector when transfected into COS cells (Faruqi et al., 1996; Faruqi et al., 2000). 
Additionally, conjugation of TFOs to mutagens can induce site-specific mutagenesis 
(Faruqi et al., 2000; Vasquez, Narayanan, & Glazer, 2000; Wang, Levy, Seidman, & 
Glazer, 1995; Wang, Seidman, & Glazer, 1996).  
 
3. Overview of Thesis Research  
The overall goal of this thesis project was to investigate the possibility of using 
platinated triplex-forming oligonucleotides (Pt-TFOs) to inhibit the expression of 
candidate genes that are important for meiotic maturation or fertilization of mouse 
oocytes. To accomplish this goal, Pt-TFO binding sites were first identified in three 
specific target genes (addressed below in Section 3.1). The interactions of selected Pt-
TFOs with short DNA duplexes that contain the TFO binding site were then 
characterized. The uptake of fluorescein-derivatized TFOs by mouse NIH3T3 cells in 
culture was then investigated using fluorescence microscopy. Finally, the ability of a 
Pt-TFO to inhibit gene expression in mouse NIH3T3 cells was examined using RT-





3.1 Oocyte Target Genes  
The target genes for these studies, Cd9, Plk1 and Cdc25b, all contain 
homopurine tracts that are potential binding sites for Pt-TFOs. 
3.1.a Cd9 
              Cd9 is a member of the Tetraspanins family of membrane proteins, which have 
unique structural features consisting of four transmembrane domains and extracellular 
amino and carboxy tail cytoplasmic subunits (See Figure 3B) (Glazar & Evans, 2009; 
Levy & Shoham, 2005). More than 30 tetraspanin homologues have been identified in 
mammals, and although they share evolutionally conserved structural features, they 
have distinct functions including regulation of cell motility, adhesion proliferation, 
differentiation, signaling and cell fusion (Boucheix & Rubinstein, 2001; Hemler, 2001). 
Tetraspanins appear to act as molecular facilitators, organizing membrane proteins such 
as integrins, tetraspanins, immunoglobulin superfamily members, and growth factor 
receptors to form stable macromolecular protein complexes in the plane of the 
membrane; these complexes are also known as tetraspanin webs (Berditchevski & 
Odintsova, 1999; Boucheix & Rubinstein, 2001; Hemler, 2003; Woods & Couchman, 
2000). CD9 has a number of cellular functions, including regulating cell motility, cell 
adhesion, mitotic functions, signaling, membrane fusion, and proliferation (Le Naour, 
Rubinstein, Jasmin, Prenant, & Boucheix, 2000; Miller, Georges-Labouesse, Primakoff, 
& Myles, 2000). 
As shown in Figure 3A, mouse CD9 consists of 8 exons spanning more than 
23 kB (Le Naour et al., 2000).  CD9 is expressed on the mouse egg plasma membrane 
(Chen & Sampson, 1999; Kaji, Oda, Miyazaki, & Kudo, 2002). Recent studies suggest 
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that CD9 is important for the interaction of egg and sperm membranes, a crucial step 
for fertilization.  Knockout studies in mice showed that Cd9
-/-
 female mice are 
infertile, though sperm could bind to the plasma membrane of zona pellucida-free 
oocytes isolated from the infertile female mice  (Figure 3B) (Kaji et al., 2000; Le 
Naour et al., 2000; Miyado et al., 2000). When an individual sperm was injected into 
oocytes isolated from Cd9-deficient mice, fertilization was rescued and these injected 
oocytes produced zygotes that developed normally (Miyado et al., 2000). 
Alternatively, the ability of Cd9-deficient oocytes to be fertilized was restored when 
human Cd9 mRNA or mouse Cd9 mRNA was injected into the Cd9
-/-
 oocytes (Le 
Naour et al., 2000; Zhu et al., 2002).   
Additionally, in vitro fertilization experiments have also been used to study the 
effect of CD9 on egg-sperm interactions. In these experiments, zona-free eggs isolated 
from female mice were incubated in the presence of anti-CD9 mouse antibodies and 
inseminated with sperms, and co-incubated.  Binding and fusion were assessed by 
microscopy (Chen & Sampson, 1999; Le Naour et al., 2000; Miller et al., 2000). 
Results from these studies demonstrated that oocytes treated with anti-CD9 mouse  
antibody had reduced sperm-oocyte fusion (Chen & Sampson, 1999; Le Naour et al., 
2000; Miller et al., 2000). These results have been replicated in other models, including 
pigs (Li et al., 2004).  
The combination of the anti-CD9 antibody and Cd9 knockout mice studies 
suggests that CD9 is involved in sperm-egg gamete membrane interactions. The 
specific molecular role of CD9 in the molecular mechanism of this event(s) of 
fertilization is unknown. The sequence-specific interactions of Pt-TFOs can be 
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exploited as a genetic modulation technique to manipulate the expression of CD9 in 
oocytes, producing a new way to contribute to studies of the molecular interactions or 
functions of CD9 in oocyte research. 
 
3.1.b Polo-like Kinase 1 (Plk1) 
Polo-like kinase 1 (PLK1) belongs to the family of conserved serine/threonine 
Polo-Like Kinases (PLK) that regulate the cell cycle and various mitotic stages 
including entry and exit into the M-phase, and spindle assembly (Glover, Hagan, & 
Tavares, 1998; Pahlavan et al., 2000; Strebhardt & Ullrich, 2006). Structurally, PLKs 
have a kinase domain at the amino terminus and a polo-box-binding domain at the 
carboxy terminus(Strebhardt & Ullrich, 2006). There are four mammalian PLK 
homologues, PLK1, PLK2, PLK3, and PLK4 (Glover et al., 1998; Pahlavan et al., 
2000; Strebhardt & Ullrich, 2006).   
PLK1 is a G2/M transition regulator with key roles in multiple processes such 
as  cell proliferation, cell cycle progression, microtubule organization, and cytokinesis 
(Glover et al., 1998; Tong et al., 2002; Watanabe et al., 2004). Over-expression of 
Plk1 has been associated with several malignancies such as non-small cell lung cancer, 
breast cancer, endometrium and ovarian cancer (Eckerdt, Yuan, & Strebhardt, 2005; 
Shi et al., 2010; Strebhardt & Ullrich, 2006; Takai, Hamanaka, Yoshimatsu, & 
Miyakawa, 2005).  The Plk1 homozygous null mutations in mice are embryonically 
lethal  and Plk1
-/- 
embryos do not survive  (Lu et al., 2008), making it impossible to 
study fertilization. However, PLK1 was successfully targeted by a systemic (Dassie et 
al., 2009) and cell type-specific (McNamara et al., 2006) aptamer-siRNA combination 
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in prostate cancer cells expressing prostate-specific membrane antigen in mouse 
models. Based on this, we considered PLK1 as a potential target for TFO based gene 
inhibition studies.  
Recent studies have highlighted the role of PLK1 in oocyte maturation and fertilization. 
Using immunocytochemistry studies and embryos isolated from matings of Plk1
+/-
 
mice, Lu et al 2008, demonstrated that Plk1-null embryos did not survive, past the early 
cleavage stages of development, suggesting that PLK1 may play a significant role in 
normal cell cycle progression (Lu et al., 2008). Using a combination of microinjection 
and immunoprecipitation studies, Ito et al., 2008 demonstrated that overexpression of 
the PLK1 polo-box domain (Plk1 PBD) mRNA in oocytes resulted in delayed Germinal 
Vesicle Breakdown (GVBD) during in vitro meiotic maturation, but the oocytes were 
still able to complete the GVBD stage, while an overexpression of a constitively active 
Plk1 substrate, CA (T210D)-Plk1 mRNA, accelerated progression through meiotic 
maturation (Ito et al., 2008).  Collectively, their research suggests that Plk1 is required 
for maturation of oocytes.   Furthermore, microinjection of anti-PLK1 mouse antibodies 
into mouse oocyte causes delayed germinal vesicle breakdown rate and distorted 
spindle organization during meiosis (Tong et al., 2002). As it is difficult to generate a 
viable knockout Plk1 mouse, the sequence specificity of TFOs can potentially be 
harnessed to target the Plk1 gene to inhibit its transcription to generate Plk1-deficient 
oocytes for studies.  




3.1.c  Cell division cycle 25b (Cdc25b)   
Cell division cycle 25b (CDC25b) is a member of the cyclin division cycle 25 
(CDC25) serine / threonine protein phosphatases that regulate cell cycle division by 
controlling the G2/M phase transition (Galaktionov & Beach, 1991). Structural 
features of the CDC25 phosphatases include the highly conserved C-terminal catalytic 
domain and the variable amino terminal regions. In mammals, there are three CDC25 
homologues, CDC25a, CDC25b and CDC25c (Lindqvist et al., 2004; Sohn et al., 
2004). CDC25B activates the CDK1-cyclin B complexes during G2/M and is involved 
in fundamental cell cycle control, thus affecting many cellular processes including cell 
growth, survival, and proliferation (Draetta & Eckstein, 1997; Galaktionov & Beach, 
1991; Lindqvist et al., 2004).  
In mammalian species, oocytes are arrested at prophase of meiosis I prior to 
ovulation (Sen & Caiazza, 2013).  One of the most important mechanisms for 
resumption of meiosis and exit from this prophase I arrest is the activation of cyclin-
dependent   kinase-1 (CDK1) (Lincoln et al., 2002).  Using Cdc25b
-/-
 female mice, 
Lincoln et al. (2002) demonstrated that Cdc25b is required for meiotic resumption. 
Female mice deficient in Cdc25b were sterile, though their ovaries were normal 
(Lincoln et al., 2002). Microinjection of wild-type Cdc25b mRNA into oocytes from 
Cdc25b
-/-
 females resulted in the resumption of meiosis (Lincoln et al., 2002). In rat 
oocytes, antibodies against CDC25b interfered with the oocyte’s ability to undergo 
germinal vesicle breakdown (Gershon, Galiani, & Dekel, 2006).  
In summary, the importance of the Cd9, Plk1 and Cdc25b in fertilization and 
oocyte maturation has been demonstrated by a variety of studies, including analyses of 
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oocytes from knockout mice (in cases where these knockout animals are available and 
viable), and various methods to perturb function or expression of the proteins. 
However, these knockout methods are time-consuming, labor-intensive and costly. 
Targeting these genes with Pt-TFOs presents an opportunity to harness the sequence 
specificity and potential long-term effects of Pt-TFOs as a potential technique for 
modulating gene expression.  Furthermore, with the advent of advanced and robust 
whole genome sequencing, the DNA sequences of genes involved in oocyte biology 
will be readily available and the successful initial applications of Pt-TFOs will set a 
precedent for new and effective direct gene modulation approaches for exploring the 
functions of key genes in oocytes.  
 
3.2 Research approaches  
In the thesis research I used two experimental approaches, in vitro biochemical 
assays to characterize the biochemical properties of Pt-TFOs the triplex and in vivo  
biological assays using cultured mouse NIH3T3 cells. Pt-TFOs were designed based 
on identifying TFOs binding sites in the target genes using a web-based search engine.  
The in vitro experiments included characterizing the interaction of TFOs and Pt-TFOs 
with short DNA duplexes that contain the TFO binding sites using gel electrophoretic 
mobility shift assays and UV thermal denaturation experiments.  The in vivo assays 
consisted of examining the uptake of fluorescein-derivatized inert Pt-TFOs  (Inert Pt-
TFO is chemically inactive and does  not crosslink to the DNA target) by cultured 
mouse NIH3T3 cells with fluorescence microscopy and assessing the ability of the 
fluorescein-derivatized active Pt-TFOs to inhibit gene expression in mouse NIH3T3 
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cells using RT-qPCR and western blot techniques.  The experiments performed are 
outlined below.  
 
 3.2. a  Identification of Pt-TFO Binding Sites 
 A web-based search engine (Gaddis et al., 2006) was used to identify 
homopurine tracts in mouse Cd9, Plk1 and Cdc25b genes that could be targeted by Pt-
TFOs. This search engine allows the user to search different regions of the genes 
including introns, exons, and promoters with specific parameters such as length of 
sequence, % GC, pyrimidine interruptions and options to mask repeated sequences 
(Gaddis et al., 2006). Homopurine tracts appear to be a surprisingly common feature 
of mammalian genes. For example, Wu et al. (2007) used the search engine to identify 
triplex-forming target sequences in the complete human and mouse genome and found 
at least one potential TFO binding site localized in the promoter and or transcribed 
regions in 97.8% of human and 95.2% of mouse genes (Wu et al., 2007). An 
additional consideration for finding Pt-TFO binding sites was the presence of a 
guanine residue adjacent to the TFO binding site that would enable the Pt-TFO to 
cross-link to the DNA target. As I will address below in Section 3.2.d, studies in this 
thesis research largely focused on Cd9-targeting TFOs.  
  
3.2.b Interaction of TFOs and Pt-TFOs with their target binding sites 
The interactions of TFOs and Pt-TFOs containing either pyrimidine deoxyribo- 
or pyrimidine 2'-O-methylribonucleotides with short DNA duplexes were assessed by 
ultraviolet (UV) thermal denaturation experiments or by gel electrophoretic mobility 
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shift assays (EMSA) (Campbell & Miller, 2009a; Campbell & Miller, 2009b; 
Guieysse, Praseuth, Giovannangeli, Asseline, & Hélène, 2000; Havre, Gunther, 
Gasparro, & Glazer, 1993). Thermal denaturation experiments were used to assess the 
ability of TFOs to form triplexes with DNA duplexes containing their cognate binding 
sites. The thermal stability of the triplexes was monitored as a function of pH.  
EMSA was used to determine the cross-linking efficiency of Pt-TFOs with 
their DNA targets. In these experiments the target DNA duplex is end labeled with a 
5-terminal-
32
P-phosphate group. The labeled duplex is incubated with the Pt-TFO; the 
reaction mixture is subjected to electrophoresis on a denaturing polyacrylamide gel 
(PAGE); and the products of the reaction are detected by phosphorimaging the gel 
(Campbell & Miller, 2009a; Campbell & Miller, 2009b; Graham & Miller, 2012).  The 
electrophoretic mobility of the labeled strand of the duplex that has cross-linked to the 
Pt-TFO is less than that of the non-cross-linked labeled strand of the duplex. 
Quantification of each labeled strand on the gel allows determination of the percent 
cross-linking by the Pt-TFO. 
 
3.2.c  Uptake of Fluorescein-Derivatized TFOs by Mouse NIH3T3 Cells in 
Culture 
As noted above, in vivo experiments consisted of examining the uptake of 
fluorescein-derivatized inert platinated TFOs (Inert Pt-TFOs) by cultured mouse 
NIH3T3 cells. This necessitated use of transfection as a non-viral based approach of 
transferring nucleic acids into mammalian cells (Malone, Felgner, & Verma, 1989; 
Noguchi, Furuno, Kawaura, & Nakanishi, 1998). There are a variety of transfection 
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methods including physical approaches such as microinjection and electroporation, 
and approaches that use transfection agents such as cationic liposome and polymers. 
While several transfection methods are available for cellular delivery of nucleic acids, 
they all have limitations in terms of transfection efficiency, cellular toxicity, and 
reproducibility.   
One of the most significant challenges to nucleic acid transfection is traversing 
the plasma membrane with a hydrophilic, negatively charged nucleic acid. To 
circumvent this problem, commercially available cationic liposomal and polymers 
have been developed. Most cationic transfection reagents rely on the electrostatic 
interactions between the negatively charged nucleic acid phosphates and the positively 
charged head groups of the cationic lipid. These interactions effectively mask the 
negative charge of the nucleic acid, and impart an overall positive charge to the 
complex (Duan, Zhang, Wang, Yang, & Zhi, 2009). The mechanism(s) by which the 
DNA-cationic liposome/polymer complex enters the cell is not well understood, 
although studies suggest that the DNA-cationic liposome/polymer complex is taken up 
by endocytosis (Wrobel & Collins, 1995; Zabner, Fasbender, Moninger, Poellinger, & 
Welsh, 1995). Once in the cell, the complex dissociates the endosome and releases the 
nucleic acid into the cytoplasm where it is subsequently distributed to different 
cellular compartments (Crooke, 1992; Felgner et al., 1987; Felgner & Ringold, 1989; 
Noguchi et al., 1998).   
The ultimate destination of the nucleic acid could be affected by the 
composition of the transfection agent. Therefore we performed comparative in vivo 




 2000 and the cationic polymer FuGENE HD. Both transfection 
agents were assessed for their cellular delivery, uptake efficiency and nuclear 
localization of a fluorescein labeled inert Pt-TFO in NIH3T3 mouse fibroblast cells.  
The number of cells with fluorescein-labeled inert Pt-TFO compared to the number of 
endogenous DNA per image was used to estimate the uptake efficiency. Three 
independent fields of cells were analyzed and the results averaged.   
 
3.2.d  Biological Effects of a Cd9-Targeting Pt-TFO Mouse NIH3T3 Cells in 
Culture 
The ability of a Pt-TFO to inhibit Cd9 gene expression was evaluated using (1) 
a standard reverse transcriptase quantative polymerase chain reaction (RT-qPCR) to 
assess changes in mRNA transcript levels; and (2) western blotting to evaluate any 
reduction in CD9 protein expression. In both assays, cells treated with either a 
scrambled Pt-TFO and a Cd9-specific TFO were compared to control cells treated 
with only transfection agent. 
Given the results of preliminary screening experiments, which indicated that 
the deoxy-Cd9 specific TFOs had significant binding affinity to the Cd9 DNA target 
and the platinated Cd9-specific TFOs effectively cross-linked to their target DNA, we 
selected the Cd9 target gene for further studies. Hence, the bulk of the thesis research 
focuses on the in vitro characterization and in vivo investigation of the inhibitory 




MATERIALS AND METHODS 
 
All regents were purchased from Sigma (St. Louis, MO) unless otherwise noted. 
Sso Advanced SYBR Green was purchased from (Bio-Rad, CA). Monoclonal rat anti-
mouse antibody to CD9 (BD Biosciences, CA) and HRP-conjugated goat anti-rat IgG (80 
ng/ml) were obtained from Janice Evans' Lab (BMB, JHSPH). Monoclonal anti-beta-
actin antibody (0.5 mg/ml stock) and HRP-conjugated goat anti-mouse IgG (0.5 mg/ml) 
were generously provided by Pierre Couloumbe’s Lab (BMB, JHSPH).  2'-0 -
methoxyribo-5-methylcytosine and 2'- 0 -methoxyribothymine phosphoramidites were 
purchased from ChemGenes (Ashland, MA) and 6-fluorescein phosphoramidites were 
purchased from Glen Research (Sterling, VA). NIH3T3 mouse fibroblast cells 
(generously provided by Pierre Coloumbe’s Lab -JHSPH BMB). 
 
1. Cell culture and TFOs and transfections  
NIH3T3 mouse fibroblast cells were maintained in Dulbecco’s Modified Eagle 
Medium (DMEM)  (Gibco/Invitrogen, Carlsbad, CA) supplemented with 10% fetal 
bovine serum (Gibco/Invitrogen, Carlsbad, CA), 100 U/mL penicillin, and 100 µg/mL 
streptomycin incubated at 37
o
C with 5% CO2.  
  
2. Oligonucleotides design  
The sequences of all TFOs (except Scrambled TFO) were obtained using the 
Triplex-Forming Oligonucleotide  (TFO) Target Sequence Search (Gaddis et al., 2006) 
using the following criteria: Species-mouse, minimum TFO target sequence length of 15 
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nucleotides, a minimum 50% Guanine content, with or without pyrimidine interruptions.  
The extinction coefficients of all TFOs were calculated using the Oligo Calc: 
Oligonucleotide Properties Calculator (Kibbe, 2007). The sequences of all 
oligonucleotide and the DNA duplexes used are given in Table 1.  
   
3. Oligo-2’-0-methylribonucleotides synthesis 
The 2’-O-methylribonucleotide-modified oligonucleotides containing 2’-0 -
methoxyribo-5-methylcytosine, 2’-0-methoxyribothymine, 6-carboxyfluorescein (6-
FAM) conjugated to the 5’ end of the TFO) and deoxyriboguanosine were synthesized on 
an Applied Biosystem ABI 3400 automated DNA/RNA synthesizer.  All 
phosphoramidites used in the synthesis were prepared as 0.15 M solutions and the 
oligonucleotides were synthesized on a controlled pore glass (CPG) containing 1 µmol of 
the terminal 3’ nucleotide of each sequence. The coupling reactions were activated by 5 
ethylthiotetrazole, and coupled at 360 s for all 2’-0-methylribonucleotide 
phosphoramidites and 120 s for deoxyribonucleotides. Following synthesis, the CPG- 
bound oligonucleotides were washed with 10 mL of dry acetonitrile, and dried on a 
vacuum pump. The CPG-bound oligonucleotides were dissolved in a solution of 300 µL 
of concentrated ammonium hydroxide and 100 µL of 95% ethanol and incubated at 55
0
C 
for 18 hours to deprotect and release the oligonucleotides from the CPG support. The 
supernatant was removed, and the supports were washed four times with 200 µL of 50 % 
aqueous acetonitrile. The supernatants were combined and evaporated to dryness on a 
SpeedVac concentrator. The residue was redisssolved in 500 µL of 50% acetonitrile and 
stored at 4
o
C.  The purities of the oligonucleotides were confirmed by strong anion 
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exchange high-performance liquid chromatography (HPLC) on a Dionex DNAPac PA 
100 4 mm x 250 mm column (Dionex, Sunnyvale, CA, USA) using 0-0.5 M sodium 
chloride in a buffer containing 100 mM tris (hydroxymethyl) aminomethane (pH 7.8) and 
10% HPLC grade methanol at a flow rate of 1.0 mL/min over a 30 min gradient. To 
confirm the compositions of the TFOs, matrix matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) was performed at the Johns Hopkins School of Medicine 
AB Mass Spectrometry/Proteomics Facility.  
Fluorescein-labeled 2’-0-methylribonucleotides oligonucleotides were 
synthesized as described above with the addition of 6-fluorescein phosphoramidites. 
 
4.  Platination of TFOs 
Eleven nmol of TFO were evaporated to dryness on a SpeedVac  and the residue, 
redisssolved in a buffer containing 400 µL of water and 100 µL of 1 mM trans -
diamminedichloroplatinum(II) dinitrate, and the solution incubated for 1 h at 37
0
C. The 
platinated TFO was purified by HPLC and desalted on a Waters Sep-Pak-Vac column 
(Waters, Milford, MA). The UV absorption spectra of the Pt-TFOs were recorded and 
their concentrations determined using extinction coefficients determined from an 
oligonucleotide properties calculator (Kibbe, 2007). 
5. Thermal denaturation experiments 
Triplex formation and stability were determined by recording a UV melting 
curves. For each reaction, a solution of 0.5 µM of DNA duplex and 0.5 µM of TFO or 
platinated TFO in 1mL of triplex buffer (pH 6.0, 7.0, or 7.5), containing 50 mM 2-(N -




for 10 minutes in a sand bath and slowly cooled to room temperature.  The absorbances 
of the triplex solutions were monitored in a Cary 3E UV-vis spectrophotometer as a 




C at a heating rate of 0.4
o
C/min. The 
normalized hyperchromism of the absorbance, calculated using the formula (A1-A0)/ 
(Af-A1) (where A indicates absorbance, 0-varying, 1-initial, f-final), was plotted against 
the temperature to determine the melting temperature of triplex. 
 
6. Denaturing gel electrophoretic mobility shift assays (EMSA)/ cross-linking 
To study the interactions of the Pt-TFO with the DNA duplex, an electrophoretic 
mobility shift assay was carried out using 
32
-P as tracer.  A 1 µM solution of the purine-
containing strand of the target duplex was labeled with a solution containing 1µL of T4 
polynucleotide kinase, 10 µL of ATP and y- [
32
P]ATP (specific activity  10  µci/mmol), 
and 3.2 µL of water. To remove unreacted 
32
-P ATP, the reaction was run through a G-25 
spin column. An equimolar amount of the unlabeled complementary strand was added 
and the solution was evaporated to dryness on a Speed Vac. Triplex buffer (of varying 
pH, 250 µL) was added to the mixture, the solution was incubated at 60
o
C for10 minutes, 
cooled to room temperature and stored at 4
o
C.  To analyze cross-link formation, 10 µL of 
the 
32
-P labeled duplex was added to increasing concentrations of the TFO (0-10uM) and 
incubated at 37
o
C overnight. Ten microliters of gel loading buffer (80% formamide, 
0.03% bromophenol blue, and 0.03% xylene cyanol) was added to each reaction mixture 
and a 10 µL aliquot of the solution was subjected to electrophoresis at 800 V on a 20% 
denaturing polyacrylamide gel (18 cm x 20 cm) in tris (hydroxymethyl) aminomethane– 
borate–EDTA buffer. The gel was imaged on a FujiFLA-7000 phosphorimager and the 
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percent cross-linking was determined by comparing band densities using ImageGuage.  
 
7. Transfection of NIH3T3 cells with TFO 
 To investigate the effects of the TFOs on expression of the CD9 gene in NIH3T3 
cells in culture, NIH3T3 cells grown to 80% confluency were seeded into 35mm cell 
culture dishes at  8x10
5  
cells per dish and incubated overnight. The cells, which were 
approximately 30-40% confluent, were then transfected with TFO. For all protocols, two 
transfection regents FuGENE HD (Promega Madison, WI) and Lipofectamine TM 
2000(Carlsbad, CA) in a 1:3 DNA: transfection regent ratio were used to determine the 
optimal transfection regent.  
For FuGENE HD transfections, 4 µg of Pt-TFO (20 µL of 200 ng/µL fluorescein-
labeled CD9 T2 3’ TFO or fluorescein- labeled Scrambled  3’ TFO) were diluted with 
100 µL of Opti-MEM (Invitrogen, Carlsbad, CA) and 12 µL of FuGENE HD  was 
diluted with100 µL of Opti-MEM. The two solutions were mixed by pipetting 15 times 
and incubated for 15 minutes. Complete growth medium was removed from the seeded 
NIH3T3  cells and replaced with 200 µL of DNA : FuGENE HD complex  and 1.8 mL of 
NIH3T3 complete growth medium. The reaction mixture was incubated for 72 hours 
without medium change  and prepped or harvested for specific assays.  
For Lipofectamine 2000 transfections, 2 µg of Pt-TFO (10 µL of 200 ng/µL 
fluorescein-labeled CD9 T2 3’ TFO or fluorescein- labeled scrambled  3' TFO) was  
diluted in 250 µL of Opti-MEM. Lipofectamine 2000 (6 µL) was diluted in 250 µL of 
Opti-MEM and the solution incubated for 15 minutes. The  diluted DNA and diluted 
Lipofectamine 2000 were gently mixed by pipetting and incubated for 20 minutes. 
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Complete growth medium was removed from the seeded cells  and replaced with 500 µL 
of DNA: Lipofectamine 2000 complex in 1.5mL of Opti-MEM. The cells were incubated 
for 2 hours in the transfection medium, after which it was removed and replaced with  
regular cell culture medium. The transfection was  repeated 24 hours after the initial 
transfection and the cells incubated for 48 hours  post second transfection before 
prepping or harvesting for specific assays. 
Negative control experiments were performed for all transfections where cells 
were either treated with just FuGENE HD or Lipofectamine 2000. 
 
8. Cellular uptake and localization  
NIH3T3 cells were seeded on glass bottom wells and transfected with inert Pt-
TFOs  using FuGENE HD and Lipofectamine 2000 as previously described. 72 hours 
post transfection (FuGENE) or 48 hours post second dose transfection (Lipofectamine), 
the cells were fixed with a solution of 1 mL of phosphate-buffered saline  [PBS] (Quality 
biological, Gaithersburg, MD) and 3.2 µL of 1ng/µL Hoechst stain (Invitrogen) for 25 
minutes. Live cell images were acquired using a Zeiss  510 Meta LSM microscope with 
Zeiss software. Three random images were captured and averaged for uptake efficiency, 
which was estimated by calculating the ratio of cells exhibiting green fluorescence from 
the inert Pt-TFO to those exhibiting blue fluorescence from the Hoechst staining of DNA.  
40X images were captured to  determine where the TFO  were localized in the transfected 
cells.    
9. RT-qPCR  
NIH3T3 cells were transfected  with fluorescein-labeled  scrambled and CD9 3’ 
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Pt TFOs  using  FuGENE HD and Lipofectamine 2000 following the previously describe 
protocol, although the number of cells seeded and  amount of all regents used were 
doubled. That is  16x10
5
 cells were transfected, 8 µg of Pt-TFO (40 µL of 200 ng/µL)  
and 24 µL of FuGENE HD were used  for FuGENE HD  transfection and 4 ug  of Pt-
TFO (20 µL of 200 ng/µL of Pt-TFO)  and 12 µL of Lipofectamine 2000 were used for  
each Lipofectamine  2000 transfection (transfection repeated 24 hours after the first 
transfection).  Seventy-two hours post transfection (FuGENE) or 48 hours post second 
transfection (Lipofectamine), the cells were trypsinized for 5 minutes at 37
o
C, 
centrifuged at 300 xg for 5 minutes and the supernatant discarded.  The cells were 
washed again with 2 mL PBS and centrifuged at 300 xg for 5 minutes and the supernatant 
discarded. Total RNA was extracted from the cells using an RNase Mini Kit (Qiagen, 
Valencia, CA, Cat#74106) according to the manufacturer’s instructions. Primers for CD9 
were adapted from Huang et al. (2011) and primers for GAPDH (PrimerBank ID 
6679937a1) were designed using the PrimerBank search engine (Harvard/MGI).  CD9 
primers were F- 5’ –CTGGCATTGCAGTGCTTGCTA-3’, R- 5’-
AACCCGAAGAACAATCCCAGC-3’ and GAPDH primers were F- 5’- 
AGGTCGGTGTGAACGGATTTG-3’ and R-5’-TGTAGACCATGTAGTTGAGGTCA-
3’ (Huang et al, 2011). For  real time reverse transcription quantitative polymerase chain 
reaction (RT-qPCR), 1 µg of RNA was reversed  transcribed  using  a solution of  1µL of  
SYBR green master mix and  4 µL of 5x reaction mixture and excess nuclease free water 
at a final volume of 20 µL.  The cDNA reaction mixtures were diluted with 60 µL of 
nuclease free water. The resulting cDNAs were stored frozen at -20
0
C for further use.  
For each qPCR reaction, 8 µL of the cDNA reaction mixture, 1.5 µL of  5 µM forward 
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and reverse primers, 10 µL of SsoAdvanced  SYBR Green supermix ( Bio-Rad, Hercules, 
CA ) and 0.5 µL of nuclease-free water were mixed together. RT-qPCR was performed in 
a Bio-Rad 7000 thermocycler  using  the following thermocycle profile which was 
adapted from  Weimin et al (2011): 5 minutes at 50
o
C, 10 minutes at 94
o
C, followed by 
40 cycles of 15 seconds at 94
o
C and 1 minute at 60
o
C.  
To optimize the conditions for the qPCR, a  standard curve was prepared as 
follows: 16 X 10
5
 NIH3T3 cells were seeded in a 60mm cell culture plate  and incubated 
for 72 hours and total RNA were extracted and reverse transcribed to cDNA as described 
above. Five, 1:10 serial dilutions of the cDNA were prepared qPCR was preformed on 
each dilution  following the Weimin’s protocol as previously described. The Cycle 
threshold (Ct)  values for each dilution  were plotted against the log of the cDNA 
concentration resulting in a linear graph. Excel statistical functions were used to 
determine the slope and R
2
 value of the linear graph. PCR efficiency was calculated using 
the slope and efficiency calculator from Thermo Fisher Scientific (qPCR efficiency 
calculator).  
10. Statistical Analysis  
For treated and untreated cells, the 2
- ΔΔCt
 relative quantitative  method was used to  
assess  changes in the target genes expression post transfection. 2
-ΔΔCt
 is used to quantify 
the  amount of  target genes in a treated sample that is  normalized  to an endogenous 
reference gene and  compared to the expression of the target gene in a  untreated control 
sample (Livak & Schmittgen, 2001). The 2
-ΔΔCt
 was calculated as follows: 
ΔCt (treated cells) = Ct (CD9 target gene) - Ct (Gapdh reference gene) 
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  ΔCt (untreated/negative control) = Ct (CD9 target gene) - Ct (Gapdh reference 
gene) 
ΔΔCt = (ΔCt treated cells- ΔCt untreated) 
And fold change = 2 
–ΔΔC  
All the results are shown as averages +/- standard deviation. All the data were 
analyzed using Microsoft Excel statistical functions.  
 
11. Western Blots  
NIH3T3 cells were transfected  with  fluorescein-labeled  scrambled and CD9 3’ 
Pt TFOs  using  FuGENE HD and Lipofectamine 2000 as previously described. Seventy-
two hours post transfection (FuGENE HD) or 48 hours post second transfection 
(Lipofectamine 2000), the cells were washed in 2 mL ice cold phosphate-buffered saline  
[PBS] (Quality biological, Gaithersburg, MD ) and 250 mL of cold Lysis buffer (50 mM 
of Tris-HCl, pH 7.6), 150 mM NaCl, 1% Triton-x-100, 0.5% Sodium Deoxycholate, and 
4.68 mL ddH20). 0.25 µL of Protease inhibitor cocktail inhibitor (Sigma, St. Louis, MO) 
was added  immediately. A cold plastic cell scraper was gently used to scrape the 
adherent cells for a few minutes  and the cells were maintained at constant agitation for 
30 minutes at 4
o
C. The cell suspension was then transferred to a pre-cooled centrifuge 
tube and centrifuged at 12000 X g at 4
o
C for 15 minutes.  The supernatant was removed 
and placed in a fresh pre-cooled tube, and the pellet was discarded.   The protein 
concentrations were measured using a Nanodrop spectrophotometer. The protein was 
stored frozen at 4
o
C until further use. Forty micrograms of untreated, fluorescein-labeled 
scrambled 3’ Pt-TFO, fluorescein-labeled CD9 3’Pt-TFO protein samples were added to 
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10 µL of 2X sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel 
electrophoresis (SDS-PAGE) sample buffer and briefly centrifuged. As a positive control 
for CD9 on the immunoblot, 20 ng  mouse liver lysate were prepared from a 5 µg/µL 
stock solution  of liver lysate. Fifteen µL of protein sample and 10 µL of  protein marker 
(Bio-Rad, Hercules, CA, Cat#161-0374) were the loaded onto a non-reducing 12.5% 
SDS-PAGE and  the gel was run for 1.5 h at 1500V. Resolved proteins on the gel were 
transferred to a piece of immobilon (Millipore, Billerica, MA) following a standard 
transfer protocol at 100 V for 1.30 hours.  After the transfer, the blot was divided into 
two, and each membrane was blocked overnight in PBS containing 5% BSA and 0.1% 
Tween-20. The lower portion of the membrane was incubated in 1: 5000 dilution of 
KMC8.8, a rat monoclonal CD9 antibody (1mg/ml stock, BD Bioscience, San Jose, CA) 
in PBS with 0.1%  Tween and 3% bovine serum  albumin [BSA] overnight to probe for 
CD9 protein. The upper portion of the membrane was probed for beta-actin by incubating 
the membrane with a 1: 5000 dilution of monoclonal anti beta-actin mouse antibody in 
PBS containing 0.1%  Tween and 3% BSA. The lower and upper portions of the 
membrane were washed four times in a solution containing PBS and 0.1% Tween  for 15 
minutes each and then incubated with  1:5000 HRP-conjugated goat anti-rat IgG (Janice 
Evans Lab) in a solution containing PBS, 0.1% Tween and 3% BSA for 1 hour and 1: 
2000 HRP-conjugated goat anti-mouse IgG (Pierre Couloumbe Lab) in a solution 
containing PBS, 0.1% Tween and 3% BSA for 1 hour respectively. The blot was then 
washed 8 times in a solution containing PBS and 0.1% Tween for 2 hours and detected  
with  a 1:1 dilution of ECL Supersignal West Pico Substrate (Pierce, Rockford, IL) for 5 
minutes.  Protein bands were visualized with FluorChem HD2 system and quantitative 
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In the following experiments, two forms of platinated TFOs are used. TFOs are 
either platinated with an active N7-trans-diaminechloroplatinum- or inert N7-
diethelentraimineplatinum-deoxyguanosine residue.  The active Pt-TFOs can cross-
link to guanine residues in their target DNAs. This reaction anchors the TFO to the 
target DNA.  The inactive Pt-TFOs are not chemically reactive and therefore unable to 
cross-link to their targets.  Throughout the thesis Pt-TFO denotes a TFO with an active 
platinum and inert Pt-TFO denotes a TFO with an inactive platinum.  
 
1.   Selecting Pt-TFO Sequences to Target Homopurine Tracts in Cd9, Plk1, and 
Cdc25b. 
We used the triplex forming oligonucleotide search engine (Gaddis et al., 
2006) to identify homopurine tracts in the Plk1, Cd9 and Cdc25b genes that would be 
amendable to triple helix formation and cross-linking.  Several potential target 
sequences were included in the results. To select specific TFO sequences for studies, 
we used criteria that have been defined through experimental studies of triplexes, 
based on factors that generally stabilize triplex formation. These factors serve as 
predictors of triplex stability and are used to select potential TFO sequences. They 
include the nucleotide length and composition of the TFO sequence, purine 
interruptions (Campbell & Miller, 2009a; Sandström, Wärmländer, Gräslund, & 
Leijon, 2002), low cytosine content, position of the terminal guanine and specific 
strand of the DNA duplex the TFO interacts with (Graham & Miller, 2012). Generally, 
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the stability of the TFO increases with increasing length.  However, for our purposes, 
a minimum of length of 15 nucleotides with no more than one purine interruption was 
used to select the TFO sequences as purine interruptions tend to destabilize the triplex 
formation(Campbell & Miller, 2009a). Additionally, TFO sequences with contiguous 
cytosines residues were avoided due to the pH dependency of the C.GC triads. 
Furthermore, TFOs with terminal guanine on the 3' end of the TFO tend to form more 
stable triplexes than those with 5' terminal guanine and were preferred, though we 
selected sequences with either the terminal guanine on the 3' or 5' end and sometimes 
on both 3' and 5' ends to study the effects of the guanine on triplex stability. Finally, 
we selected TFOs that bind to and cross-link to the transcribed strand of the DNA 
because they have the potential to induce greater inhibition of gene expression. 
However, we made exceptions for these if the TFO conformed to the other parameters. 
These criteria should produce a TFO that can theoretically bind and cross-link to the 
target sequence. Therefore, the TFO sequences that conformed to the specified criteria 
were chosen for preliminary studies and are presented in Table 1.  3' TFO denotes 
TFOs with the terminal guanine on the 3' end of the TFO and the 5' TFO denotes 
TFOs with the terminal guanine on the 5’ end.  
 
2.    Interactions of TFOs and Pt-TFOs with DNA Duplexes  
Two of the most commonly used methods to identify TFOs and Pt-TFOs that 
could bind efficiently to homopurine tracts in the gene targets are UV thermal 
denaturation and electrophoretic mobility shift assay (EMSA). In these assays the  
 33 
experiments are performed using short DNA sequences corresponding to the target 
DNA duplexes.  
The multistep process begins with performing thermal denaturation assays at 
three pH conditions (6, 7 and 7.5) to screen a panel of deoxyribose-TFOs to identify 
those with at least 35
o
C melting temperatures (Tm) at physiological pH (7~7.5). We 
initially examined deoxyribo-TFOs because they are readily obtained from 
commercial sources and contain no base or backbone modifications.  
In general, deoxy-TFOs form triplexes of low stability because the B-
conformation of these TFOs is not compatible with the A-like conformation of the 
triplex.  Although most deoxyribo- TFOs will form stable triplexes at low pH (pH 6); 
the binding results at pH 6 cannot be completely relied upon as predictors of triplex 
binding stability under physiological conditions. Because deoxyribo-TFOs rarely form 
stable triplexes at pH 7.5 or above(Graham & Miller, 2012), in our experiments Tm 
values were determined at pH 7. Based on the results of these binding experiments, 
deoxyribo-TFOs giving the most stable triplexes were selected, platinated with active 
transplatin and their ability to cross-link to target DNA assessed by EMSA. 
 Studies suggest that the 2'-0-methylribose TFO modification increases the Tm 
of the triplex by at least 30
o
C (Graham & Miller, 2012). Based on these observations, 
and the results from melting experiments with the deoxyribo-TFOs and cross-linking 
experiments with deoxyribo-Pt-TFO, deoxyribo-TFOs with high Tm that can cross-link 
to their DNA targets when platinated were selected for modification with 2'-0-
methylribonucelotide residues. The Tm values of triplexes formed by these 2'-O-
methylribo-TFOs were determined and those 2'-O-methylribo-TFOs that gave high Tm 
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values under physiological conditions (pH 7.5) were selected, platinated with active 
transplatin and their abilities to cross-link to their targets were assessed using EMSA.  
 
2.1   Deoxyribo-TFOs and Pt-TFOs 
 The thermal stabilities of triplexes formed by deoxyribo-TFOs with DNA duplexes 
containing the cognate binding site were examined using UV thermal denaturation 
experiments. Solutions containing equimolar concentrations of the deoxy-TFO and 
target DNA duplex in pH 7.0 triplex buffer were   heated at 90
o
C for 10 min and then 
allowed to slowly cool to room temperature. The absorbance of the solution at 260 nm 
was monitored as the solution was heated at a rate of 0.4°C/min over a temperature 
range of 4-85
o
C. The normalized hyperchromicity  (A0-A1)/(Af-A1) (where A indicates 
absorbance, 0-varying, 1-initial, f-final), was plotted against temperature to determine 
the melting temperature of the triplex.  Figure 4A shows a typical melting curve. The 
melting curve of the triplex (black curve) reveals two transitions: the first transition 
corresponds to melting of the third strand and the second transition corresponds to 
melting of the duplex into its respective single strands.  The melting curve of the duplex 
alone (red curve) reveals one transition, which corresponds to the melting of the duplex 
into single strands.  
Figure 4B shows the melting temperatures of the third strand of the triplexes 
formed by TFOs that target Cd9, Plk1 and Cdc25b DNA at pH 7.0. All triplexes were 
stable at 20
o
C, though some bound with higher stability to their target than others. Cd9 




C respectively  
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(Fig. 4B). All the Cd9 T2 TFO (18 nucleotides) had similar Tms, with Cd9 T2 3' TFO, 







C respectively (Fig. 4B).  Similarly, Cd9 T3 3' TFO, Cd9 T3 5' TFO (19 




C. Cd9 T6 5' 
TFO had a Tm of 34 
o
C and Cdc25b-T1 5' TFO had a Tm of 34 
o
C. However, Plk1 T2 
3' TFO, Cdc25b-T1 3' TFO, Cdc25b-T2 3' TFO and Cdc25b T2 5' TFO had the lowest 








C respectively (Fig. 4B).  
The abilities of the platinum-derivatives of the TFOs described above to cross-
link to their DNA targets were then examined. The 3'- or 5'-terminal guanines of the 
TFOs were platinated by reacting the TFO with trans- diaminediaaquaplatinum (II) 
dinitrate. The Pt-TFOs were purified by strong anion exchange (SAX) HPLC. The 
platinated TFO (0-100 pmol) was reacted with its target DNA duplex (10 pmol), 
whose purine strand was end labeled with 
32
P at 37°C. The reaction mixture was 
subjected to electrophoresis on a denaturing polyacrylamide gel. The gel was scanned 
by a phosphorimager and the percentage of cross-linking was determined from band 
intensities using Image Gauge software.  The cross-linking reactions were performed 
in triplicate. 
A representative gel is shown in Figure 5A, where the slower migrating band 
corresponds to the Pt-TFO cross-linked to the labeled purine strand of the duplex. The 
extent of cross-linking increased with increasing concentration of Pt-TFO. Figure 5B 
shows the percent cross-linking of 10 µM deoxyribo-Pt-TFOs to their cognate DNA 
targets.  At pH 6.0, all of the deoxyribo-Pt-TFOs cross-linked to their respective 
targets with varying efficiencies. Eight percent of Plk1 3' Pt-TFO cross-linked to its 
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duplex DNA, while only 2% of Cdc25b T1 3' Pt-TFO cross-linked to its target DNA 
(Fig. 5B). Sixty-one percent of Cdc25b T1 5' Pt-TFO cross-linked to its target, and 3% 
of Cdc25b T2 3' Pt-TFO cross-linked to its target and 45% of Cdc25b T2 5' Pt-TFO 
cross-linked to its target. The highest levels of cross-linking were observed for Pt-
TFOs that targeted Cd9 (Fig. 5B). Fifty-five percent of Cd9 T1 3' Pt-TFO cross-linked 
to their targets, while 73% of Cd9 T1 5' Pt-TFO cross-linked to their targets.  Thirty-
one percent of Cd9 T2 3' Pt-TFO cross-linked to its target while 73% and 73 % of Cd9 
T1 3' Pt-TFO, Cd9 T2 5' Pt-TFO cross-linked to their targets respectively. Nineteen 
percent of Cd9 T3 3' Pt-TFO, 45% of Cd9 T3 5' TFO and 12% of Cd9 T6 5' Pt-TFO 
cross-linked to their targets (Fig. 5B).  
The extent of cross-linking is dependent upon pH. At pH 7.0, neither Plk1 3' 
Pt-TFO, Cdc25b T1 3' Pt-TFO, Cdc25b T1 5' Pt-TFO, Cdc25b T2 3' Pt-TFO, Cdc25b 
T2 5' Pt-TFO cross-linked to their targets. Additionally, only 2% of Cd9 T1 3' Pt-TFO 
and 3% of Cd9 T1 5' Pt-TFO cross-linked to their targets. Cd9 T2 3' Pt-TFO had the 
highest cross-linking efficiency, with 14% of the Pt-TFO cross-linking to its target, 
while only 6% of Cd9 T2 5' Pt-TFO cross-linked to its target despite having similar 
melting temperature and similar nucleotide composition. Surprisingly, Cd9 T2 3' and 
5' Pt-TFO did not cross-linked to its target DNA. Twelve percent of Cd9T3 3’ Pt-TFO 
cross-linked to its target and 11% of Cd9 T3 5' Pt-TFO cross-linked to its target and 





2.2     2'-O-Methylribo-TFOs and Pt-TFOs 
         Based on the binding and cross-linking results, the Cd9 T2 3' TFO and Cd9 T2 5' 
TFO sequences were chosen for further study. Cd9 T2 3' TFO had the highest cross-
linking (14%) despite having a Tm of 38°C and Cd9 T2 5' TFO had a Tm of 36°C and a 
slightly lower cross-linking of 6%.  Previous studies have shown that 2'-O-methylribo-
Pt-TFOs have increased binding and cross-linking efficiency and are less susceptible to 
nuclease digestion in comparison to their deoxyribo-counterparts (Campbell & Miller, 
2009a; Graham & Miller, 2012). To determine if similar results could be achieved with 
the Cd9-specific TFOs, we synthesized modified Cd9 T2 3' and 5’ TFO with a 2'-O-
methyribonucleotide backbone, 5-methylcytosines, 5-methyluridine, and 
deoxyguanosines at the 3' or 5' ends using a standard automated synthesis procedure. 
HPLC analysis indicated the presence of two distinct peaks for both Cd9 T2 3' and 5' 
TFO, which could indicate cleavage of the oligonucleotide or incomplete synthesis. 
Mass spectrometry was performed to determine which peak corresponded to the desired 
TFO. The expected mass for both 2'-OMe Cd9 T2 3’ TFO and 5' TFO is 5944.1 (Table 
2).  For both TFOs, samples from the second peak of the HPLC chromatographs were 
found to have masses corresponding to the expected values:  5943.2585 for 2'-O-Me 
Cd9 T2 3' TFO and 5942.7873 for 2'-OMe Cd9 T2 5' TFO (Table 2).  
Thermal denaturation experiments were carried out as described above for the  
deoxyribo-TFOs.  A representative melting curve is shown in Figure 6. The black curve 
represents melting of the duplex into single stands and the red curve shows melting of 
the third strand from the triplex. In contrast to the melting curve of the triplexes formed 
by the deoxyribo-TFOs, there is only one transition in the melting curve of the triplex 
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formed by the 2'-O-methylribo-TFO (Fig. 6). This single transition suggests that the 
third strand and duplex melt at the same temperature, which occurs at a temperature 
higher than that of the duplex alone. At pH 7.0, 2'-O-Me Cd9 T2 3' TFO had a Tm of 
76°C and 2'-O-Me Cd9 T2 5' TFO had a Tm of 70°C (Table 2).  At pH 7.5, the Tm 
decreased, with the Tm of 68
o
C for 2'-O-Me Cd9 T2 3' TFO and a Tm of 61°C
 
for 2'-O-
Me Cd9 T2 5' TFO (Table 2).  
Gel electrophoretic mobility shift assays were performed as described above to 
assess the cross-linking efficiencies of the 2'-O-Me-Pt-TFOs targeted to the Cd9 gene. 
The cross-linking experiments were performed in triplicate, and the results presented 
in Table 2. Under the experimental conditions and at pH 6.0, 32% of Cd9 T2 3' Pt- 
TFO and 40% of 2'-OMe Cd9 T2 5' Pt-TFO cross-linked to the target duplex DNA 
(Table 2). In contrast to the behavior of the deoxyribo-Pt-TFOs, significant levels of 
cross-linking were observed at pH 7.0 and pH 7.5. At pH 7.0, 35% of Cd9 T2 3' Pt-
TFO and 63% of 2'-OMe Cd9 T2 3’Pt-TFO cross-linked to the target DNA (Table 2). 
At pH 7.5, 33% of 2'-O-Me Cd9 T2 3' Pt-TFO and 40% of 2'-O-Me Cd9 T2 5' Pt-TFO 
cross-linked to the target DNA (Table 2).  
 
2.3  Fluorescein-Derivatized 2'-O-Me-Pt-TFOs  
           Fluorescein-derivatized Pt-TFOs were prepared for use in live cell imaging by 
fluorescence microscopy to monitor localization of the oligonucleotide in the cells. A  
5'-FITC-labeled 2'-O-Me Cd9 T2 3' TFO having the same nucleotide composition and 
sequence as the 2'-O-Me Cd9 T2 3' TFO was synthesized for studies in cultured cells 
(Table 1). A previously synthesized fluorescein labeled scrambled 3' TFO with similar 
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nucleotide composition as Cd9 T2 3' TFO but slightly greater length was used as a 
positive control in the cell culture experiments (Table 1).  
To determine the efficiency of binding and cross-linking of the FITC-labeled 
2'-OMe Cd9 T2 3’ TFO, thermal denaturation and electrophoretic mobility shift assays 
were performed with both FITC labeled 2'-O-Me Cd9 T2 3' TFO and the FITC labeled 
2’-O-Me scrambled 3' TFO and their platinated derivatives..  
 The results of the binding assay are shown in Figure 7A. At pH 7.0, FITC- 
labeled 2'-O-Me Cd9 T2 3' TFO had a Tm of 74°C, whereas the FITC-labeled 
scrambled 3’ TFO had a Tm of 20°C (Fig. 7A). However, platination with inert 
platinum decreased the thermal stability of FITC- labeled 2'-O-Me Cd9 T2 3' Pt-TFO 
to 67°C whereas the stability of FITC labeled 2'-O-Me scrambled 3' PT-TFO 
increased to 33°C (Fig. 7A). 
To determine whether the active platinated scrambled TFO could react with the 
target duplex, 100 pmol of Pt- FITC-labeled scrambled 2'-OMe 3' Pt- TFO was 
incubated with the Cd9 T2 3' target DNA and the results were analyzed by gel 
electrophoresis under denaturing conditions.  Similar experiments were performed for 
the 2'-O-Me Cd9 T2 3' Pt-TFO and  FITC labeled 2'-OMe Cd9 T2 3' Pt-TFO. The 
extent of cross-linking was determined from the relative intensities of the bands 
resulting from triplex formation. As shown in Figure 7B, triplex formation is only 
observed in the presence of the 2'-O-Me Cd9 3' Pt-TFO and FITC labeled 2'-O-Me 
Cd9 T2 3' Pt-TFO.  26%, 26% and 31% of FITC-labeled 2'-OMe Cd9 specific Pt-TFO 
cross-linked to the purine strand of the DNA target at pH 6.0, 7.0 and 7.5 respectively. 
For the FITC-labeled Cd9 T2 3' Pt-TFO, the cross-linking efficiencies were similar, 
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24%, 27% at pH 6.0 and 7.0 respectively, except at pH 7.5, where it decreased slightly 
to 21% (Fig. 7B).  
 
3.      Uptake of Fluorescein-Derivatized 2'-O-Me-Pt-TFOs by NIH3T3 Cells in 
Culture  
To assess the cellular delivery of an inert-Pt-TFO (TFO conjugated with a 
chemically inactive form of the transplatin which does not interact with and cross-link 
to the target DNA duplex) and its localization in the cell, NIH3T3 cells were 
transfected with 678 pmoles of FITC labeled 2’-OMe Cd9 T2 3’ inert Pt-TFO in 
2mL/well using either Lipofectamine 
TM
 2000 and FuGENE HD respectively; fixed 
with PBS; and stained with Hoechst, a dye that stains nucleic acids and only fluoresces 
when it binds to the major groove of the duplex DNA(Adolf, Aschberger, & Pelster, 
2013). 
The live cells were examined by fluorescence microscopy. Three different 
fields of cells were examined in each experiment. The uptake efficiency was estimated  
by calculating the ratio of the cells exhibiting green fluorescence from the inert Pt-
TFO to those exhibiting blue fluorescence from the Hoechst staining of DNA. The 
green fluorescence thus signals cells that have taken up the inert Pt-TFO, whereas the 
blue fluorescence represents the total number of cells in the field of view.  
Representative images are shown in Figure 8. In Figure 8A, the phase contrast image 
of the cells is in Panel 1, cells that have taken up the inert Pt-TFO are shown in Panel 
2, the total number of cells as indicated by Hoechst staining are shown in Panel 3 and 
Panel 4 shows the image of Panel 2 merged with Panel 3.  
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A significant number of cells take up the inert Pt-TFO. Approximately 79% of 
the cells took up the inert Pt-TFO when complexed with Lipofectamine
TM
 2000, 
whereas a slightly higher percentage of the cells, 84%, took up the inert Pt-TFO when 
complexed with FuGENE HD (Fig. 8A). Examination of the cells at 40x 
magnification revealed that the inert Pt-TFO was mainly localized in the nucleus.  As 
shown in Figure 8B, inert Pt-TFOs transfected using Lipofectamine
TM
 2000 were 
primarily localized in the nucleus, whereas in the cells transfected with FuGENE HD, 
the FITC-labeled TFOs were found to be distributed in the nucleus and cytoplasm. 
 
4. Effect of Cd9-Specific 2’-O-Me-Pt-TFO on Cd9 mRNA and CD9 protein levels in 
NIH3T3 Cells 
 
4.1    RT-qPCR Assays 
   Preliminary RT-qPCR experiments were carried out to determine the effect of 
the 2’-OMe Cd9 specific Pt- TFO on gene expression in NIH3T3 cells.  In these 
experiments we used the mCd9 primers described by Huang et al. (Huang et al., 2011) 
to monitor Cd9 mRNA levels and mGapdh primers (Spandidos et al., 2010) to monitor 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) mRNA levels. GAPDH is a 
housekeeping gene that is commonly used in qPCR protocols to normalize for 
differences in mRNA recoveries in RT-qPCR experiments (Radonić et al., 2004).  The 
RT-qPCR assays were optimized to achieve increased sensitivity specificity and 
reproducibility over a dynamic linear range. One of the most common methods of 
optimizing RT-qPCR reactions is to perform the assay on serial dilutions of the cDNA 
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and plot the cycle threshold (Ct) values against the log of the cDNA concentrations to 
obtain a standard curve. The sequences and product size of the mCd9 (mouse Cd9) 
primer (Huang et al., 2011)and mGapdh (mouse Gapdh) primers (Spandidos et al., 
2010) used in the RT-qPCR are shown in Table 3. Three replicates were run for each 
dilution, over a 5-fold dilution range. Figure 9A is the plot of the standard curve.  
Several criteria define the characteristics of the standard curve.  For an effective 
protocol, the slope of the standard curve should be between -3.2 and -3.5, as a 100% 
efficient assay will  result in a standard curve with a slope of -3.3(Nolan et al., 2006). 
Additionally, the R
2
 value is used to measure the reproducibility of the assay and is 
expected to be >0.98 to indicate that the assay is reliable and reproducible. The slopes 
and efficiency of the target and the housekeeping primers should be similar as this 
indicates similar sensitivity (Nolan et al., 2006). This is important as data obtained from 
the RT-qPCR reaction is normalized to the endogenous housekeeping gene to internally 
control for errors in the protocol (Nolan et al., 2006). In Figure 9A, the slope for Cd9 is 
-3.1035 with an R
2
 of 0.99692, an efficiency of 109.99% and the slope for Gapdh is -
3.288, R
2
 of 0.99768, which translates into an efficiency of 101.40%.   
One way to determine the quality of the RNA transcript and the RT-qPCR 
protocol is to run the products on an agarose gel. Figure 9B shows the products of the 
RT-qPCR reactions run on an agarose gel.  As can be seen, there are no degraded or 
truncated RNA products and the products of Cd9 II and Gapdh I are of the correct 
size, 208 kb and 123 kb respectively (Table 3).  
To analyze the effect of the Cd9 T2 3’ Pt-TFO on the Cd9 mRNA level, 




 2000 at a total concentration of 0.7 nmol/dish and harvested 72 hours 
or 48 hours post transfection respectively. Total RNA was extracted from the cells and 
RT-qPCR was used to analyze the Cd9 mRNA transcript levels using Cd9-specific 
primers, with Gapdh-specific primers used as a control. The levels of mRNA 
expression were measured using the cycle threshold (Ct). The relative fold change in 
expression was calculated using the 2
ΔΔCt
 method (Livak & Schmittgen, 2001) where 
the average of delta Ct values for the Cd9 mRNA was normalized to that of Gapdh 
mRNA control and compared to untreated control cells to control for any internal 
variations in the RT-qPCR.  
The results are shown in Figure 10. These data are representative of two 
independent experiments performed in triplicate. Vertical bars represent the standard 
deviation from the mean for the two replicates. For transfection with FuGENE, the 
FITC scrambled 3' Pt-TFO mRNA expression was 86% (± 0.25) of the untreated cells, 
and the FITC Cd9 3' Pt-TFO mRNA expression was 94% (± 0.25) of the untreated 
cells (Fig. 10).  For transfection with Lipofectamine
TM
 2000, the control FITC labeled 
scrambled 3' Pt-TFO mRNA expression was 68 % (± 0.05) of the untreated cells, and 
the FITC-labeled Cd9 3' Pt-TFO mRNA expression was 71 % (± 0.06) (Fig. 10).  
 
4.2   Western Blot Analysis 
  A Western blot was used to determine if the changes observed in the mRNA 
after Pt-TFO treatments were also reflected in the CD9 protein level. The cells were 
transfected with FITC labeled scrambled Pt-TFO and FITC labeled Cd9 T2 3' Pt- TFO 
as previously described. The cells were lysed and the whole cell lysate was subjected to 
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SDS-PAGE followed by western blotting. Beta-actin was used as a loading control. The 
blot was analyzed by ImageJ. The ratio of CD9 expression to beta-actin expression were 
determined using Image J (NIH). All CD9 protein levels were first normalized to beta-
actin protein expression levels to control for variation in loading. The results were then 
expressed as a percentage of the level of control cells. The blot is shown in Figure 11A 
and the quantitative analysis presented in the bar graph in Figure 11B. The level of CD9 
protein in cells transfected using FuGENE HD were comparable in FITC-labeled 
scrambled 3' Pt-TFO (97% of CD9 protein in untreated) and FITC-labeled Cd9 3' Pt-
TFO (95% of CD9 protein in untreated) treated cells (Fig.11B). Similar results were 
obtained for cells transfected using Lipofectamine
TM
 2000 regents where the CD9 
protein levels were comparable in cells transfected with FITC-labeled scrambled Pt-
TFOs (100% of CD9 proteins in untreated) and cells transfected with FITC-labeled Cd9 
T2 3' Pt-TFOs (90% of CD9 protein in untreated) (Fig.11B).  
For the RT-qPCR and western blotting analyses, the statistical significance (p-











Triplex-forming oligonucleotides (TFOs) react with their target DNA in a 
sequence specific manner to inhibit gene expression, an approach that makes them 
attractive as tools for selectively manipulating the activity of genes. The overall goal 
of this thesis project was to investigate the possibility of using triplex forming 
oligonucleotides to inhibit expression of genes that are important for the maturation or 
fertilization of oocytes in a mouse cell culture model system. The specific aims of the 
project included the identification of TFO binding sites in the target genes, 
characterizing the interactions of the TFO with short DNA duplexes that contain the 
TFO binding sites, investigating the uptake of the fluorescein-derivatized TFOs by 
mouse NIH3T3 cells in cell culture using fluorescence microscopy and examining the 
ability of the platinated TFOs to inhibit gene expression in mouse NIH3T3 cells using 
RT-qPCR and western blot techniques.  
The three target genes studied were Cd9, Plk1, and Cdc25b. We used a web-
base search engine (Gaddis et al., 2006) to screen the three genes for potential TFO 
binding sites. The following criteria were used in this search: minimum TFO length of 
15 nucleotides, low cytosine content, no contiguous cytosine sequences, and a 
maximum of one pyrimidine interruption. Theoretically, these criteria should identify 
TFOs that can form triplexes with their target DNA duplexes, however, biophysical 
and biochemical studies are performed to characterize the interaction of the TFOs and 




1.    Interactions of TFOs and Pt-TFOs with DNA Duplexes  
 
1.1.a  Deoxyribose-TFOs and Deoxyribo-Pt-TFOs 
  As can be seen from the results, the thermal stabilities of the triplexes formed 
by deoxyribo-TFOs seem to be dependent on length and cytosine content of the TFO 
sequence. For example, triplexes formed by Cd9 T3 3' TFO and Cd9 T3 5' TFO had 
higher slightly higher Tms than those formed by Cd9 T2 3' and 5' TFO targets (19 
nucleotides and 21% cytosine content compared to 18 nucleotides and 27.7% cytosines 
respectively). This is consistent with observations in previous studies where TFOs with 
longer nucleotide sequence and lower cytosine content tend to form more stable 
triplexes (Campbell & Miller, 2009a; Crooke, 1992; Graham & Miller, 2012). However, 
an exception to this observation is the Cd9 T1 3' TFO and Cd9 T1 TFO 5' TFO, which 
despite the 18 nucleotide length and 50% cytosine content, had Tms of 42°C and 45°C 
respectively. Similarly, both Cdc25b T1 3' and 5' TFOs are 17 nucleotides in length 
with 35% cytosine content, but the 3' TFO had  lower Tm (23°C)  than the 5' TFO 
(34°C). While this might suggest that a 5' terminal guanine provides more stability than 
a 3' terminal guanine, these differences vary for almost all the targets. All these 
observations suggest that several factors, in addition to nucleotide length, cytosine 
content, and position of the terminal guanine in the TFO, might be involved in defining 
the stability of triplexes formed by the TFO. In support of this notion, Graham et al 
(2012) have shown that sequences flanking the TFO binding site can affect TFO 
binding affinity (Graham & Miller, 2012).  
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The extend of cross-linking by deoxyribo-Pt-TFOs is dependent on pH. At pH 
6, all of the deoxyribo-Pt-TFOs cross-linked at pH 6 with different efficiencies (Fig. 
5B).  
However, as the pH increased, the extent of cross-linking decreased 
dramatically. The absence of triplex formation at pH 7.0 by Plk1-3' Pt-TFO, Cdc25b 
T1 3' Pt-TFO,  Cdc25b T1 5' Pt-TFO, Cdc25b T2 3' Pt-TFO, Cdc25b T2  5' Pt-TFO 
imply that while these Pt-TFOs are capable of binding to their target duplexes,  their 
triplex formation occur at Tm lower than the experimental  conditions (37
o
C), which 
suggest that inefficient binding interactions under the experimental conditions does 
not favor cross-linking with the target DNA (Fig. 5b). An exception to this is Cd9-2 3' 
& 5' Pt-TFO, whose 3' and 5' terminal guanines are both platinated. Despites it’s Tm 
above the experimental condition of 37°C, it did not cross-link to its target DNA, 
though it was assumed that the double platination would increase the cross-linking 
efficiency.  
In addition, it was observed that at pH 6, all deoxyribose 5’ Pt-TFOs cross-
linked at higher efficiency than 3’ Pt-TFOs. While this may suggest that the platinum 
on the 5’ terminus of the TFO increased its cross-linking efficiency, this pattern of 
cross-linking was not observed at pH 7, where the cross-linking was highly variable 
despite similarities in Tm for both 3’ and 5’ TFOs of each target DNA. With this 
variable cross-linking at different pH conditions, it difficult to conclusively determine 
any specific relationship between the terminal platination and cross-linking efficiency. 
Additionally, previous experiments performed by Graham and Miller (2012) 
suggested that 3'-platination gave higher levels of cross-links as opposed to 5'-
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platination (Graham & Miller, 2012)., lending support to the idea that the efficiency of 
the cross-linking is determined in some as-yet not understood way dependent upon the 
sequences flanking the TFO binding site. 
 
1.1.b  2'-OMe TFOs and Pt-TFOs 
 As previously observed with the deoxyribo-TFOs, the Tms of  2'-OMe TFOs 
were also dependent on pH as the Tm decreased with increasing pH. However, as 
expected the Tms of the triplexes formed by 2'-OMe Cd9 T2 3' TFO and Cd9 T2 5' TFO 
were on average about 30 
o
C higher than those of the corresponding deoxyribo-TFOs 
under all experimental conditions tested (Fig. 4B, Table 2). In addition, the Tm of the 
triplex formed by 2'-OMe Cd9 T2 3' TFO was slightly higher than that of the triplex 
formed by 2'-OMe Cd9 T2 5' TFO. 
On average, at pH 7, the cross-linking efficiencies of the 2'-OMe Pt-TFOs were 
higher than their deoxyribo- Pt-TFO counterparts (Fig. 5B and 7B) In contrast to the 
deoxyribo-TFO studies, results from the 2’-OMe Pt-TFO cross-linking experiments 
show that the extent of cross-linking  is independent of pH. Thus 2'-OMe Cd9 T2 3' Pt-
TFO had similar cross-linking efficiencies over the pH range of 7.0 to 7.5 (Table 2). 
Similar results were observed for Pt-2'-OMe Cd9 T2 5' TFO. This pH independent 
cross-linking efficiency is a result of the substitution of the cytosines in the deoxyribo-
TFO with 5-methylcytosines increases triplex stability, significantly reducing the pH 
dependency of the triplex formation as they obliterate the requirement for C protonation 
to allow the triplex formation to occur.  
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As both 2'-OMe Cd9 T2 3' Pt-TFO  and 2'-OMe Cd9 T2 5' Pt-TFO have the 
same nucleotide composition and length (19 nucleotides),  and target the same sequence 
in the first intron of the Cd9 gene (Fig. 2a) any differences in triplex Tm and cross-
linking  efficiency could be due to the terminal guanines. Both of the 3' and 5' Pt-TFOs 
bind and cross-link to the same sequence in the target DNA. The Pt-TFO with the 5' 
terminal guanine is more effective at cross-linking with the target DNA though this 
observation is in contrast with observations made by Graham et al (2012). (Theses are 
2'-OMe and they have Tm in the 60s, higher than the 37 
o
C of the cross-linking 
experimental condition).  They observed that TFOs with a 3'-platinum group cross-link 
more efficiently than TFOs of the same sequence with a 5'-platinium (Graham & Miller, 
2012). This indicates that other factors such as the sequence of the TFO, neighboring 
sequences of the DNA target sequence among others contribute to the cross-linking 
efficiency of the Pt-TFO to its to its target.  
In summary, the Tm values of 2'-OMe Cd9 T2 3' TFO and Cd9 T2 5' TFO were 
at least 30 
o
C higher than their corresponding deoxyribose-TFOs and as a consequence 
their platinum derivatives cross-link with higher efficiency. This increase in Tm and 
extent of cross-linking is an effect of the stability conferred by, 2'-O-methyl and 5' 
methylcytosine modifications. These findings are in agreement with the work of 
Graham et al, (2012) and Campbell et al (2009) who demonstrated that modification of 
the TFO with 2-O-methylribose nucleotides increased the binding stability and cross-
linking efficiency of the TFO. Overall, the studies of the interactions of the TFOs and 
Pt-TFOs with DNA duplexes is consistent with previous studies that showed 2'-O-
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methyl and 5' methylcytosine modifications of the TFO decreases the pH dependency of 
the triplex formation(Maher et al., 1989) and stabilizes the triplex formation 
(Campbell & Miller, 2009a; Escudé et al., 1992; Graham & Miller, 2012; Knauert & 
Glazer, 2001b; Xodo et al., 1991). 
 
1.1.c  Fluorescein-Derivatized 2'-OMe-Pt-TFOs 
 Prior to performing cellular uptake and in vivo studies of the TFO biological 
activities, FITC-labeled 2'-OMe Cd9 T2 3' TFO was synthesized to make it easier to 
track the TFO by live cell fluorescence microscopy. We characterized the interactions 
of the fluorescein-derivatized 2'-OMe- inert-Pt-TFO with the target DNA duplex using 
UV thermal denaturation and EMSA. Similar experiments were performed using a 
scrambled 3' Pt-TFO obtained from Mindy Graham, which has a similar nucleotide 
composition to that if Cd9 T2 3' TFO (Table 1). Both the FITC-labeled 2'-OMe Cd9 
T2 3' TFO and its inert platinum derivative formed stable triplexes with the Cd9T2 
DNA. The triplex formed by FITC-labeled 2'-OMe Cd9 T2 3' TFO had a Tm similar to 
that of unlabeled 2'-OMe Cd9 T2 3' TFO (74°C and 76°C respectively), suggesting 
that the FITC label does not affect the binding interactions of the TFO with the target 
DNA (Fig. 7A). However, Platination of the FITC labeled 2'-OMe Cd9 T2 3' TFO 
decreases the Tm of the triplex to 67°C (Fig. 7A). In contrast, while the FITC-labeled 
scrambled control TFO and its derivatized platinum counterpart formed stabled 
triplexes with reasonably high Tms, they were lower than that of the FITC-labeled 2'-
OMe Cd9 T2 3' TFO (Fig.7A). 
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EMSA results indicate that FITC-labeled 2'-OMe Cd9 T2 3' Pt-TFO  cross-
links with similar efficiency to the target DNA as the unlabeled 2'-OMe Cd9 T2 3' Pt-
TFO at pH 6 and 7, in support of the previous observation that the FITC label does not 
affect the interactions of the TFO with the target as expected, the FITC-labeled 
scrambled 3' Pt-TFO did not cross-link to the Cd9 T2  DNA target at any of the pH 
conditions tested (Figure 7B).  
 
2. Uptake of Fluorescein-Derivatized 2'-OMe-Pt-TFOs by NIH3T3 Cells in Culture 
 To assess the uptake of the fluorescein-derivatized 2'-OMe Pt-TFOs, NIH3T3 
mouse fibroblast cells were transfected with the FITC-labeled 2'-OMe Cd9 3' inert Pt-
TFO. The cellular delivery and uptake efficiencies were determined by fluorescence 
microscopy. As shown in Figure 8A, the Pt-TFOs were successfully transfected into 
the mouse NIH3T3 cells. Higher uptake efficiency was observed with Pt-TFOs 
complexed with FuGENE HD than Pt-TFOs complexed with Lipofectamine
TM
 2000 
(Fig 8A).  The merge of the images of cells in Panel 4, comprising images of cells that 
have taken up the FITC- labeled TFO (Panel 2) and images of cells whose DNA is 
stained with Hoescht of DNA (Panel 3), show that the TFO is in the nucleus (Fig. 8B). 
Observation at higher magnification (40x) shows increased nuclear localization was 
observed when transfection was carried out using Lipofectamine
TM
 2000 compared to 
transfection using FuGENE HD (Fig. 8B). However Lipofectamine induced higher 
cytotoxicity (data not shown) compared with FuGENE HD. In summary, cells 
transfected with inert Pt-TFO complexed with FuGENE HD expressed high uptake 
efficiency and lower cytotoxicity, although nuclear localization was suboptimal. In 
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contrast, uptake of inert Pt-TFO complexed with LipofectamineTM 2000 was slightly 
lower although nuclear localization was higher. These differences in uptake 
efficiencies and localization could affect the ability of the Pt-TFO to inhibit CD9 
expression in the cells.  
 
3.  Effect of Cd9-Specific 2'-O-Me-Pt-TFO on Cd9 Expression in NIH3T3 Cells 
The effects of FITC-labeled 2'-O-Me- Cd9 T2 3' Pt-TFO and FITC-labeled 2'-
O-Me-scrambeled Pt-TFO on Cd9 mRNA and protein levels were determined in 
mouse NIH3T3 cells in culture.  
 
3.1.a   RT-qPCR Assays 
RT-qPCR was used to assess the levels of CD9 mRNA in cells treated with 
FITC-labeled 2'-O-Me- Cd9 T2 3' Pt-TFO and FITC-labeled 2'-O-Me-scrambeled Pt-
TFO.  The Cd9 mRNA levels are normalized to the mRNA levels of Gapdh. 
Preliminary experiments showed that FuGENE HD complexes of the FITC labeled 2’-
OMe Cd9 T2 3' Pt-TFO or the FITC-labeled scrambled TFO failed to suppress Cd9 
mRNA levels in the NIH3T3 cells. In contrast, Lipofectamine complexes of FITC-
labeled 2'-OMe Cd9 T2 3' Pt-TFO or FITC-labeled 2'-OMe scrambled Pt-TFO inhibited 
Cd9 mRNA levels by 29% and 32% respectively.  
These results show a tentative correlation between the delivery of the TFOs to 
the nucleus and the effect of the TFOs on Cd9 mRNA levels. However, because both 
the FITC labeled 2'-OMe scrambled control Pt-TFO and the FITC-labeled 2'-OMe Cd9 
T2 3' Pt-TFO inhibit Cd9 mRNA levels, we cannot conclude that the inhibitory effect 
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observed is a consequence of specific interaction of the 2'-OMe Cd9T2 3' Pt-TFO with 
the Cd9 gene.  
 
3.1.b  Western Blot Assays 
 If the TFO is able to inhibit transcription of the Cd9 gene, it would be expected 
to reduce CD9 protein levels. Western blot analysis of CD9 protein expression showed 
that the protein level in cells transfected with FITC-labeled  2'-OMe scrambled 3' Pt-
TFO or FITC Cd9 3' Pt-TFO  using both FuGENE HD or Lipofectamine
TM
 2000 
transfection regent did not change (Fig. 11). These results suggest that if TFO-mediated 
inhibition of Cd9 gene transcription had occurred it was not sufficient to significantly 
affect CD9 protein expression.  
 
4.  Summary of the effect of Cd9-Specific 2'-O-Me-Pt-TFO on Cd9 Expression in 
NIH3T3 Cells   
In analyzing the results of the experiments described above it is clear that 
despite the high binding affinity of the Cd9 TFO for its target in vitro and its ability to 
cross-link to  its target DNA sequence when platinated, the platinated TFO did not 
inhibit Cd9 gene expression in a sequence specific manner.   
 Previous studies suggest that TFOs that do not cross-link to their DNA targets 
are highly prone to displacement by transcriptional machinery of the cell and have 
limited or transient inhibitory effects (Colombier et al., 1996; Young et al., 1991). 
Based on the assumption that intracellular activity of TFOs requires the TFO to bind 
and cross-link to its target, we might expect the FITC labeled Cd9 T2 3'Pt-TFO to 
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have a minimal effect on gene expression. According to our EMSA experiments, 
approximately 25% of the FITC labeled 2’-OMe Cd9 T2 3' Pt-TFO cross-linked to its 
target DNA under physiological conditions in vitro. It seems unlikely that more 
extensive cross-linking to genomic DNA would be achieved in the cells for several 
reasons: (1) The micromolar concentrations required for efficient cross-linking in vitro 
may not be attained in the nucleus of the cell;  (2) The TFO binding site may not be 
accessible to the TFO due to association with histones or other DNA binding proteins; 
and (3) The platinium may become inactive because of reaction with other molecules, 
such as glutathione, while in the intracellular environment.  
We also observed substantial inhibition of gene expression observe in cells 
treated with the FITC-labeled scrambled control Pt-TFO.  As discussed in the previous 
section, this platinated TFO does not cross-link with the Cd9 DNA target in vitro 
(Fig.7). The observed inhibition may therefore be due to off-target effects. 
Such effects by TFOs have been reported by others (Kim et al., 1998; Morvan et 
al., 1993) and one report suggested that TFOs may exhibit non-sequence-specific 
activity through interactions with DNA polymerase (Morvan et al., 1993). Alternatively 
the scrambled Pt-TFO may interact with other homopurine tracts in the genome. A 
quick nucleotide blast of the scrambled TFO sequence against the mouse genomic and 
transcript database using the NCBI BLAST (Basic Local Alignment Search Tool 
(BLAST) program identified similar sequences in different transcripts and genes, the 
most significant of which was the mouse general transcription factor  II I (Gtf2i) 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi)  (Query id: ICI21473, molecule type: nucleic 
acid, query length-19, in mouse genome). There was a 100% sequence match with 18 
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nucleotides in several variants of the Gtf2i transcription factor. Given the sequence 
similarities, it is possible that the scramble Pt-TFO can interact with non-target 
sequences such as the one found in the gene of this transcription factor and 
consequently inhibit overall gene transcription. Investigating the effect of the scrambled 
Pt-TFO on expression of other genes could provide more insights into the potential off-
target effects of this scrambled sequence.  
 
5. Proposed changes to research protocols   
In the case of the Cd9-specific Pt-TFO, there does not appear to be a strong 
correlation between its ability to cross-link to its target DNA and its biological activity 
in vivo. To fully elucidate the inhibitory effects of the Cd9 T2 3' Pt-TFO, several 
changes to the current research methods are proposed. These include changes in the 
experimental protocols used to select TFOs and Pt-TFOs that can interact with the 
target DNA duplexes, selection of scrambled Pt-TFOs as positive controls in RT-
qPCR and western blot techniques, making changes to the reference genes used in the 
RT-qPCR protocols, exploring alternative methods of cellular delivery of TFOs and 
investigating the effects of the Cd9 T2 5’ Pt-TFO.   
 
5.1.a Changes in experimental protocols used to select TFOs and Pt-TFOs 
The results, while preliminary, suggest that there is some correlation between 
in vivo and in in vitro results as observed (for Lipofectamine-Pt-TFO complexes), a 
question remains about its sequence specificity as similar results were obtained with 
scrambled Pt-TFO.  The FITC- label on the Cd9 T2 3' Pt-TFO did not significantly 
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change its binding stability or ability to form adducts with its target DNA duplex. 
Differences observed could indicate that the in vitro experimental conditions do not 
reflect the complexities of the intracellular compartment of the cell. Therefore it is 
important that the specificity of TFO interactions with genomic DNA in cell culture 
should be considered. This is because the TFO interactions with cellular components 
such as proteins, and transcriptional proteins may all affect its intracellular activity. To 
examine the sequence specific interactions of the Pt-TFO with the target DNA, it 
might be worthwhile to develop an assay to see if the Pt-TFO reacts with cellular 
genomic DNA. This approach is currently being pursued Mindy Graham in our lab  
 
5.1.b   Selection of scrambled Pt-TFOs as positive controls in RT-qPCR and 
western blot techniques 
 These experimental studies stress the need for proper experimental controls to 
accurately analyze the effect of the Pt-TFOs on target gene expression. A scrambled 
control is important for validating any effect observed when the cells are treated with 
Pt-TFOs.  Our scrambled Pt-TFO positive control did not work for our experiments as it 
failed to correlate lack of triplex formation in vitro with the observed biological activity 
in vivo.  Ideally, the best control is a scrambled version of target TFO that affect the 
triplex stability but not the gene expression. Mahato et al. (2005) in their review noted 
that it may be difficult to design scrambled controls for polypyrimidine TFOs targeted 
to endogenous genes, as opposed to target genes inserted in plasmids (Mahato et al., 
2005), though the authors did not provide an explanation for their observation.  As the 
nucleotide BLAST results indicate, it is nearly impossible to find a scrambled sequence 
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that does not have at least partial complementarity to non-targeted genes. A better 
approach would be to use the inert platinum version of the gene-specific TFO, which 
would not be able to cross-link to its target and would be expected to give little or no 
inhibition.   
 
5.1.c   Changes to the reference genes used in the RT-qPCR protocols 
 Reliable and consistent comparative studies using RT-qPCR depends on the use of 
reference genes that are minimally affected by treatment conditions. For our assays we 
used Gapdh because it is a common housekeeping gene.  However, the consensus 
regarding the utility of Gapdh is sharply divided, with some studies presenting evidence 
in support of it (Gorzelniak, Janke, Engeli, & Sharma, 2001; Raaijmakers, van Emst, de 
Witte, Mensink, & Raymakers, 2002) while others suggest that it varies considerably 
with treatments and is unsuitable as a reference gene for data analysis (Glare, Divjak, 
Bailey, & Walters, 2002; Radonić et al., 2004; Zhong & Simons, 1999). Several 
alternatives are available, including beta actin, RNA polymerase, 18s gene. However, as 
these genes are potentially susceptible to various experimental conditions to a degree, 
using a combination of reference genes could generate more reliable and reproducible 
data set (Radonić et al., 2004). We performed comparative studies of a few reference 
genes and found that the results vary with each reference gene (data not shown). Hence 
for future studies, combinations of reference genes should be used in the RT-qPCR to 
make quantitative analysis of results more accurate.  
 
5.1.d   Exploring alternative methods of cellular delivery of TFOs 
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 As previously discussed, the ability of Pt-TFOs to inhibit the expression of the 
target gene depends on their successful cellular delivery, nuclear localization and 
intracellular stability, underlying the significance of an efficient transfection reagent 
that delivers the Pt-TFOs to the nucleus. As our FuGENE HD RT-qPCR results 
demonstrate, delivery of Pt-TFO to the cytoplasm of the cell does not translate into 
efficient TFO inhibition of target gene.  The Pt-TFOs have to be localized to the nucleus 
to interact with the endogenous DNA duplex.  
Different transfection reagents will have different successes in cellular delivery 
of the TFO. For future experiments, the transfection protocol needs to be further 
optimized, as our uptake efficiencies were not high. In addition to optimizing the 
current transfection protocol, it is important to explore alternative cellular delivery 
mechanism such as conjugation to aptamers, or other commercially available chemical 
liposomal transfection reagents. There are variations of these chemical transfection 
reagents and it might be beneficial to evaluate a few more for their effectiveness.  
 Also, use of aptamers can also be explored.  Aptamers are single-stranded DNA 
or RNA oligonucleotides that fold into unique 3D structures (Levy-Nissenbaum, 
Radovic-Moreno, Wang, Langer, & Farokhzad, 2008). Aptamers are able to bind to 
nucleic acid, proteins and sugars with high affinity, and have been adapted for specific 
cell delivery. This technology has been used to deliver siRNA to cells (FAU et al., 
1229; Zhou J FAU - Rossi, John,J. & Rossi, 0714) and should be explored for cellular 




5.1.e   Investigating the effects of the CD9 T2 5' Pt-TFO 
 Results of the binding experiments and cross-linking experiments indicate that 
the 2' OMe Cd9 T2 5' TFO has similar binding stability but increased cross-linking 
efficiency compared to that of 2'-OMe Cd9 T2 3' TFO.  In vivo analysis of the 2'-OMe 
Cd9 T2 5' Pt-TFO effect on gene expression should be performed to determine if it can 
significantly inhibit the expression of the Cd9 T2 target. Furthermore, a combination of 
TFOs each targeting different regions of the same gene could induce more pronounced 
inhibition of gene expression. Kim et al (1998) showed that co-transfecting HeLa cells 
with c-myc expressing luciferase reporter plasmid construct with two promoter regions, 
P1 and P2 respectively, targeted by two TFOs  resulted in 90% inhibition of luciferase 
activity whereas neither TFO targeting P1 or  P2 alone could significantly inhibit the 
luciferase activity (Kim et al., 1998).  It would be worthwhile to transfect the NIH3T3 
cells with both 2'-OMe Cd9 T2 3' Pt-TFO and Cd9 T2 5' Pt- TFO to determine if the 
combined Pt-TFOs can significantly inhibit Cd9 gene expression. 
      
   6.  Conclusion  
It is evident that the specific requirements of TFOs place several limitations on 
the number of target sequences amendable for triplex formation. However, nucleotide   
modifications make it possible to design TFOs capable of effectively interacting with 
their target DNAs under physiological conditions. The 2'-O-methylribo modification 
increases the stability of the triplexes formed by TFOs and the efficiency of cross-
linking by Pt-TFOs.  
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Although the FITC-labeled Cd9 T2 3' Pt-TFO demonstrated modest ability to 
inhibit the Cd9 mRNA levels we were unable to demonstrate that this inhibition was a 
sequence specific effect of the TFO.  
The results of our studies reveal some impediments to the biological 
applications of Pt-TFOs. Efficient transfection of the TFO is a necessary and critical 
requirement for TFO activity, and our results indicate that the uptake efficiency and 
nuclear localization differs for different transfection reagents. Hence effective 
transfection methods are needed. In addition to that, there is a need for an 
understanding of the intracellular activity of TFO as there seems to be a disconnect 
between the in vitro experimental results and the in vivo experimental observations, at 
least for our experiment. The in vivo applications of Pt-TFOs may require further 
understanding of the specific interactions of Pt-TFOs at the genomic level in cell 
cultures. Such understanding is also relevant to the design of better controls for our 
assays. For such reasons, we cannot completely disregard the potential of the Cd9 
TFOs to modulate the expression of the Cd9 gene. As we develop better 
understanding,  better techniques and optimized protocols, we may explore the full 
potential of these TFOs. Therefore we anticipate that these preliminary results will 
encourage further investigations aimed towards demonstrating the sequence specific 
cellular activity of the Cd9 Pt-TFOs, an approach of great interest in oocyte biology  
research. Future investigations may include using in RT-qPCR to select TFOs and Pt-
TFOs capable of interacting with their target DNA duplexes, using multiple reference 
genes in the RT-qPCR, screening for more effective scrambled control, investigating 
the ability of the 2'-OMe Cd9 T2 5' TFO to inhibit Cd9 gene expression in vivo and 
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exploring other transfection strategies to study their effects on the in vivo antigene 























Table 1.  Sequences of triplex forming oligonucleotides (TFO) and their 









Duplex   
 
 
Plk1 T2   3' 
TFO 
5’ d-GACACTTTCCTTGCCTTTTTTTTAGAT  
     CTGTGAAAGGAACGGAAAAAAAATCTA-
d   5’ 
         













Cdc25b    T1   
3' TFO 
Cdc25b    T1   
5' TFO 
5’ d-AGGGCTTTTCCTTCCTCTTTCACCT  
     TCCCGAAAAGGAAGGAGAAAGTGGA-d     
5’ 
 
         GTTTCTCCTTCCTTTTC-d         5’ 











Cdc25b   T2   3' 
TFO 
Cdc25b   T2   5' 
TFO 
5’ d-TGACTCTCTTGCTTCCTCTTTCCTGG 
     ACTGAGAGAACGAAGGAGAAAGGACC-d    
5’ 
     
        GTCTCTTGCTTCCTCTTTC-d        5’ 












Cd9  T1 3' TFO 
Cd9  T1 5' TFO 
5’ d-CAGGGAGGAGAGGAAAGGGAAGGCT 




5’     d-CTCCTCTCCTTTCCCTTG 












Cd9  T2 3' TFO 
Cd9 T2 5' TFO 




Cd9 T2 3' TFO 




     
GTCTTGAAGAAAGAGAGAGAAAAGGAAAA
-d 5’  
 
           GTTCTTTCTCTCTCTTTT -d    5’ 
           TTCTTTCTCTCTCTTTTG-d     5’ 
          GTTCTTTCTCTCTCTTTTG-d     5’ 
 
                  GTTCTTTCTCTCTCTTTT-mr     5’ 







Intron 1  
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Key: d, deoxy nucleotide, mr, 2' o-methyl modified nucleotides and C, 2'-0-methyl-
methylcytosine; Plk1 –Polo-like Kinase 1 (drosophila); Cdc25b-Cell division cycle 25 

















Cd9 T3 3' TFO 
Cd9 T3 5' TFO 
5’ d-
GCAGACTTTCTTTTTCTTTCTTCTCTCTTC 




          GTTTCTTTTTCTTTCTTCT -d    5’ 











Cd9 T6 5' TFO 
5’d-CTCAATTCTTTTCTTTCTCTTTTGGAGG 

















Table 2.   Melting temperature and electrophoretic mobility shift assay (cross-
linking) of 2'-0-methylribonucleotides Cd9 T2 3' and 5' TFO.  Melting Temperatures 
of the third strand of the triplex formed by 2'-0-methyl Cd9 T2 3'and Cd9 T2 5' TFO in 
pH 7.0 and pH 7.5 triplex buffers.  Cross-linking between platinated Cd9 3' TFO and Cd9 
5' TFO and their respective DNA duplexes.  Solutions containing 1μM 
32
P-labled DNA 
duplex and either 0, 1, 5 and 10 μM of Pt-CD9 3' TFO, Pt-CD9 3' TFO were incubated in 
pH 6, pH 7, pH 7.5 triplex buffers for 24 h at 37
o
C and the reaction mixtures were 
analyzed by electrophoresis on denaturing 20% polyacrylamide gel. Percent cross-linking 
of Pt-TFO were determined by phosphoimaging.  Dash arrow denotes the triplex and 
solid arrow denotes the Duplex.  Masses of oligonucleotides were determined by mass 
spectrometry. 
 
Table 2: Melting temperature and electrophoretic mobility shift assay (cross-







C)  Crosslinking                Mass  












CD9 3’ TFO  76 68 32 35 33 5944.11 5943.2585 





Table 3.   Primer sequences used in RT-qPCR 





















mCd9 Cd9 antigen NM_00765
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Figure 1: Triplex formation by TFO interaction with a DNA duplex. (A) A third 
strand (polypurine tract labeled in figure) binds to the major groove of the target DNA 
helix to form the triplex. (B) Triplex binding motifs -base triads of triplexes formed either 
through parallel hoogsteen (C: G: C or T: A: T) or  (C) antiparallel reverse hoogsteen (G: 
G: C or A: A: T) hydrogen bonds. (Taken from Chan et al, 2011) 
 






























Figure 2: Schematic representation of TFO cross-linking to its target DNA duplex. 
(A) TFO is platinated on the N7 of guanine and the platinated TFO forms an adduct with 
a adjacent guanine in the DNA target. (B) A representation the TFO –DNA adduct 





















Figure 2:  
   
         A.            3’ −−−GCCTCCTCTCCTTTCCCTTCC−−−5’    
         5’ −−−CGGAGGAGAGGAAAGGGAAGG−− 3’    
                
                    
Pt
GTCCTCTCCTTTCCCTT     TFO 
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Figure 3: Schematic representation of the Cd9 target and the structural features of 
CD9 protein. (A) Schematic representation of the Cd9 T2 target. (B) The general 
structure of Tetraspanins membrane proteins. Tetraspanins are composed of 4 
transmembrane domains with two extracellular loops, which mediate protein-protein 






















Figure 3:  
 
A.  
Cd9   T2 TFO (Intron 1)     
           Exon 1                                                                                                                 8 
 
   
 
  CAGAACTTCTTTCTCTCTCTTTTCCTTTT 
  GTCTTGAAGAAAGAGAGAGAAAAGGAAAA-d 5’  
       GTTCTTTCTCTCTCTTTT-mr     3’ TFO  
        TTCTTTCTCTCTCTTTTG-mr    5’ TFO 







Figure 4:  General representation of the thermal denaturation curve and the melting 
temperatures of all deoxyribonucleotides TFO. (A) A general representation of 
thermal denaturation of deoxyribose triplexes. Binding stability of the d-TFO with the 
DNA duplex is examined by thermal denaturation experiments. The DNA duplex (0.5 
μM) is incubated with 0.5 μM d-TFO in pH 7 triplex buffer [50 mM 2-(N -morpholino) 
ethanesulfonic acid or 50 mM 3-(N -morpholino) propanesulfonic acid, 100 mM NaCl, 
and 5 mM MgCl2 ] at 90
o
C for 10mins and cooled to room temperature. The absorbance 
of the reaction mixture was determined using a UV-Spectrophotometer. The normalized 
hyperchromicity  (A0-A1)/(Af-A1) is plotted against temperature to determine the 
melting temperature of the triplex.  d-deoxyribonucleotide TFO, A-absorbance. The 
triplex is represented by the black curve and the DNA duplex is represented by the red 





















Figure 5: Cross-linking reaction of d-TFO with DNA duplex. (A) General 
representation of cross-linking reaction of Pt -TFO with DNA duplex. A 1 μM solution of 
32
P labeled DNA was incubated with 0, 1, 5 and 10 μM in triplex buffer [50 mM 2-(N -
morpholino) ethanesulfonic acid or 50 mM 3-(N -morpholino) propanesulfonic acid, 100 
mM NaCl, and 5 mM MgCl2] for 18 h at 37
o
C and the resulting reaction mixtures were 
analyzed by electrophoresis on 20% denaturing polyacrylamide gel. The dotted arrow 
indicates the position of the triplex and the solid arrow indicates the position of the DNA 
duplex. (B) Pt-TFO (10 μM ) was incubated with 1 μM of DNA duplex in pH 6.0 and pH 
7.0 triplex buffer [50 mM 2-(N -morpholino) ethanesulfonic acid or 50 mM 3-(N -
morpholino) propanesulfonic acid, 100 mM NaCl, and 5 mM MgCl2] and percent cross-
linking of each Pt-TFO was determined by phosphoimaging.  The percent cross-linking 













Figure 5:  
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Figure 6.  General thermal denaturation curve of 2' 0-methylribonucleotide triplex. 
The DNA duplex (0.5 μM) is incubated with 0.5 μM Cd9 specific TFO, Pt-Cd9 specific 
TFO, Scrambled TFO or Pt-Scrambled TFO in pH 7 triplex buffer [50 mM 2-(N -
morpholino) ethanesulfonic acid or 50 mM 3-(N -morpholino) propanesulfonic acid, 100 
mM NaCl, and 5 mM MgCl2] at 90
o
C for 10 mins and cooled to room temperature and 
the absorbance of the reaction mixture determined by a UV-Spectrophotometer with 




C). The normalized hyperchromicity (A0-
A1)/(Af-A1) is plotted against temperature to determine the melting temperature of the 






























Figure 7.    Melting temperature and electrophoretic mobility shift assay (cross-
linking) of   2'-0-methyl Cd9 T2 3' Cd9 T2 3' TFO and FITC-labeled Cd9 T2 3' and 
Scrambled 3' TFO.  (A) Melting temperatures of the third strand of the triplex formed 
by of   2'-0-methyl Cd9 T2 3' CD9 T2 3' TFO and fluorescein labeled Cd9 T2 3' and 
Scrambled 3' TFO in pH 7.0 triplex buffers.  (B) Cross-linking between platinated 2' 0-
methylribonucleotides Cd9 3' TFO and FITC-labeled Cd9 3' TFO or Scrambled TFO and 
their respective DNA duplexes.  Solutions containing 10 μM of Pt- Cd9  T2 3’ TFO, Pt-
FITC Cd9 T2 3' TFO and Pt-FITC labeled Scrambled 3’ TFO and the 1 μM 
32
P-labled 
DNA duplex were incubated in pH 6, pH 7, pH 7.5 triplex buffers for 18 h at 37
o
C and 
the reaction mixtures were analyzed by electrophoresis on denaturing 20% 
polyacrylamide gel. Percent cross-linking of Pt-TFO were determined by 
phosphoimaging.  The dashed arrow denotes the triplex and the solid arrow denotes the 
duplex.  Key: D=duplex, SC=FITC-labeled Pt-Scrambled 3' TFO, Cd9 1 =Pt-Cd9 T2 3' 
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Figure 8.  Transfection of NIH3T3 cells with FITC-labeled inert Pt-Cd9 specific 3' 
TFO. (A) NIH3T3 cells were transfected with FITC-labeled inert Pt-TFO using either 
FuGENE HD (panel 2) or Lipofectamine 2000 (panel 3) transfection regents in a 1:3 TFO 
to transfection regent ratio and incubated for 72 hours and 48 hours respectively. The 
cells were stained with Hoechst (blue-DNA) and analyzed by live cell fluorescence 
microscopy (10x). Uptake efficiency determined by counting total number of TFO per 
DNA per image. Three images were taken and averaged. (B) Higher magnification (40X) 
live cell imaging of FITC-labeled Inert-TFO images of transfected cells to determine 























Figure 9:  RT-qPCR  optimization - Standard curve and agarose gel.   (A) Standard 
curve obtained from 10-fold dilutions of cDNA reversed transcribed from RNA extracted 
from NIH3T3 Cells incubated for 72 hours.  Ct values are obtained as an average of a 
triplicate.  The blue line is the Gapdh primer and the red line is the Cd9 primer. (B) The 
RT-qPCR product run on 1.5% agarose gel pre-stained with SYBR green to confirm the 
primer products. Lane 1 and 4 is 10 uL of 1.5 uL of 10 ng/uL LMW marker in 9 uL of 
loading buffer. Lane 2 is 10 uL of 3 uL of Cd9 qPCR product in 8 uL of loading buffer. 




















Figure 9:  
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Figure 10: Quantitative evaluation of Cd9mRNA expression in NIH3T3 determined 
by RT-qPCR post transfection with Cd9 T2 TFO.  Data represents the change in 
mRNA transcript levels as measured by RT-qPCR. Relative mRNA expression levels for 
Cd9 in untreated, FITC-labeled Pt- Pt-scrambled TFO and FITC-labeled Pt- Cd9 T2 3' 
TFO  transfected cells using either FuGENE HD or Lipofectamine 2000 as quantified by 
RT-qPCR. The relative expressions were determined using the 2
ΔΔCt 
 methods with 
Gapdh as the endogenous control. Data represents the mean of two independent 




























Figure 11: Quantitative evaluation of inhibition of the CD9 protein in NIH3T3 
evaluated by Western blotting.  NIH3T3 cells were transfected with only the 
transfection reagent (LipofectamineTM 2000 and FuGENE HD), FITC-labeled 
Scrambled 3' TFO, or FITC-labeled CD9 T2 3' TFO.  NIH3T3 lysates collected after 
treatment with TFO and probed with the CD9 antibody (lower panel) and top blot probed 
with the beta-actin antibody (upper panel).  The band intensities of the CD9 proteins were 
normalized to the beta actin and compared to the  untreated control. Data represent means 
of two replicates ± standard deviation.  Transfection of   FITC-labeled CD9 T2 3' TFO in 
mouse NIH3T3  using  either FuGENE HD or Lipofectamine does not change the protein 
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